LXF-289 |
Growth inhibition assay |
|
|
|
Inhibition of human LXF-289 cell growth in a cell viability assay, IC50 = 0.0000066 μM. |
SANGER |
NCI-H2342 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H2342 cell growth in a cell viability assay, IC50 = 0.0000093 μM. |
SANGER |
SK-MES-1 |
Growth inhibition assay |
|
|
|
Inhibition of human SK-MES-1 cell growth in a cell viability assay, IC50 = 0.0000097 μM. |
SANGER |
NCCIT |
Growth inhibition assay |
|
|
|
Inhibition of human NCCIT cell growth in a cell viability assay, IC50 = 0.0000196 μM. |
SANGER |
CGTH-W-1 |
Growth inhibition assay |
|
|
|
Inhibition of human CGTH-W-1 cell growth in a cell viability assay, IC50 = 0.0000209 μM. |
SANGER |
Capan-2 |
Growth inhibition assay |
|
|
|
Inhibition of human Capan-2 cell growth in a cell viability assay, IC50 = 0.0000216 μM. |
SANGER |
MC116 |
Growth inhibition assay |
|
|
|
Inhibition of human MC116 cell growth in a cell viability assay, IC50 = 0.0000245 μM. |
SANGER |
786-0 |
Growth inhibition assay |
|
|
|
Inhibition of human 786-0 cell growth in a cell viability assay, IC50 = 0.0000248 μM. |
SANGER |
MES-SA |
Growth inhibition assay |
|
|
|
Inhibition of human MES-SA cell growth in a cell viability assay, IC50 = 0.0000268 μM. |
SANGER |
ES1 |
Growth inhibition assay |
|
|
|
Inhibition of human ES1 cell growth in a cell viability assay, IC50 = 0.0000365 μM. |
SANGER |
A4-Fuk |
Growth inhibition assay |
|
|
|
Inhibition of human A4-Fuk cell growth in a cell viability assay, IC50 = 0.0000518 μM. |
SANGER |
IGROV-1 |
Growth inhibition assay |
|
|
|
Inhibition of human IGROV-1 cell growth in a cell viability assay, IC50 = 0.0000607 μM. |
SANGER |
PSN1 |
Growth inhibition assay |
|
|
|
Inhibition of human PSN1 cell growth in a cell viability assay, IC50 = 0.0000669 μM. |
SANGER |
8505C |
Growth inhibition assay |
|
|
|
Inhibition of human 8505C cell growth in a cell viability assay, IC50 = 0.0000762 μM. |
SANGER |
NOS-1 |
Growth inhibition assay |
|
|
|
Inhibition of human NOS-1 cell growth in a cell viability assay, IC50 = 0.0000825 μM. |
SANGER |
D-283MED |
Growth inhibition assay |
|
|
|
Inhibition of human D-283MED cell growth in a cell viability assay, IC50 = 0.000084 μM. |
SANGER |
A375 |
Growth inhibition assay |
|
|
|
Inhibition of human A375 cell growth in a cell viability assay, IC50 = 0.0000892 μM. |
SANGER |
PANC-03-27 |
Growth inhibition assay |
|
|
|
Inhibition of human PANC-03-27 cell growth in a cell viability assay, IC50 = 0.0000911 μM. |
SANGER |
KYSE-140 |
Growth inhibition assay |
|
|
|
Inhibition of human KYSE-140 cell growth in a cell viability assay, IC50 = 0.0000924 μM. |
SANGER |
COLO-679 |
Growth inhibition assay |
|
|
|
Inhibition of human COLO-679 cell growth in a cell viability assay, IC50 = 0.0001093 μM. |
SANGER |
HT-1080 |
Growth inhibition assay |
|
|
|
Inhibition of human HT-1080 cell growth in a cell viability assay, IC50 = 0.000112 μM. |
SANGER |
NALM-6 |
Growth inhibition assay |
|
|
|
Inhibition of human NALM-6 cell growth in a cell viability assay, IC50 = 0.0001121 μM. |
SANGER |
KYSE-410 |
Growth inhibition assay |
|
|
|
Inhibition of human KYSE-410 cell growth in a cell viability assay, IC50 = 0.0001212 μM. |
SANGER |
HCC2998 |
Growth inhibition assay |
|
|
|
Inhibition of human HCC2998 cell growth in a cell viability assay, IC50 = 0.0001274 μM. |
SANGER |
CAL-12T |
Growth inhibition assay |
|
|
|
Inhibition of human CAL-12T cell growth in a cell viability assay, IC50 = 0.000128 μM. |
SANGER |
HGC-27 |
Growth inhibition assay |
|
|
|
Inhibition of human HGC-27 cell growth in a cell viability assay, IC50 = 0.0001307 μM. |
SANGER |
ES4 |
Growth inhibition assay |
|
|
|
Inhibition of human ES4 cell growth in a cell viability assay, IC50 = 0.0001308 μM. |
SANGER |
MCF7 |
Growth inhibition assay |
|
|
|
Inhibition of human MCF7 cell growth in a cell viability assay, IC50 = 0.0001314 μM. |
SANGER |
LCLC-97TM1 |
Growth inhibition assay |
|
|
|
Inhibition of human LCLC-97TM1 cell growth in a cell viability assay, IC50 = 0.0001384 μM. |
SANGER |
ES6 |
Growth inhibition assay |
|
|
|
Inhibition of human ES6 cell growth in a cell viability assay, IC50 = 0.0001401 μM. |
SANGER |
BL-41 |
Growth inhibition assay |
|
|
|
Inhibition of human BL-41 cell growth in a cell viability assay, IC50 = 0.0001413 μM. |
SANGER |
NY |
Growth inhibition assay |
|
|
|
Inhibition of human NY cell growth in a cell viability assay, IC50 = 0.0001449 μM. |
SANGER |
SW1710 |
Growth inhibition assay |
|
|
|
Inhibition of human SW1710 cell growth in a cell viability assay, IC50 = 0.0001495 μM. |
SANGER |
MZ1-PC |
Growth inhibition assay |
|
|
|
Inhibition of human MZ1-PC cell growth in a cell viability assay, IC50 = 0.0001521 μM. |
SANGER |
CAL-27 |
Growth inhibition assay |
|
|
|
Inhibition of human CAL-27 cell growth in a cell viability assay, IC50 = 0.0001685 μM. |
SANGER |
LCLC-103H |
Growth inhibition assay |
|
|
|
Inhibition of human LCLC-103H cell growth in a cell viability assay, IC50 = 0.0001725 μM. |
SANGER |
DMS-273 |
Growth inhibition assay |
|
|
|
Inhibition of human DMS-273 cell growth in a cell viability assay, IC50 = 0.00018 μM. |
SANGER |
KYSE-70 |
Growth inhibition assay |
|
|
|
Inhibition of human KYSE-70 cell growth in a cell viability assay, IC50 = 0.0001805 μM. |
SANGER |
MEL-JUSO |
Growth inhibition assay |
|
|
|
Inhibition of human MEL-JUSO cell growth in a cell viability assay, IC50 = 0.0001854 μM. |
SANGER |
NCI-H520 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H520 cell growth in a cell viability assay, IC50 = 0.000191 μM. |
SANGER |
A2780 |
Growth inhibition assay |
|
|
|
Inhibition of human A2780 cell growth in a cell viability assay, IC50 = 0.0001964 μM. |
SANGER |
TGBC24TKB |
Growth inhibition assay |
|
|
|
Inhibition of human TGBC24TKB cell growth in a cell viability assay, IC50 = 0.0002024 μM. |
SANGER |
OPM-2 |
Growth inhibition assay |
|
|
|
Inhibition of human OPM-2 cell growth in a cell viability assay, IC50 = 0.0002164 μM. |
SANGER |
AN3-CA |
Growth inhibition assay |
|
|
|
Inhibition of human AN3-CA cell growth in a cell viability assay, IC50 = 0.0002178 μM. |
SANGER |
KGN |
Growth inhibition assay |
|
|
|
Inhibition of human KGN cell growth in a cell viability assay, IC50 = 0.0002222 μM. |
SANGER |
SK-LMS-1 |
Growth inhibition assay |
|
|
|
Inhibition of human SK-LMS-1 cell growth in a cell viability assay, IC50 = 0.0002255 μM. |
SANGER |
HuH-7 |
Growth inhibition assay |
|
|
|
Inhibition of human HuH-7 cell growth in a cell viability assay, IC50 = 0.0002396 μM. |
SANGER |
A172 |
Growth inhibition assay |
|
|
|
Inhibition of human A172 cell growth in a cell viability assay, IC50 = 0.0002543 μM. |
SANGER |
OVCAR-3 |
Growth inhibition assay |
|
|
|
Inhibition of human OVCAR-3 cell growth in a cell viability assay, IC50 = 0.0002778 μM. |
SANGER |
NCI-H358 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H358 cell growth in a cell viability assay, IC50 = 0.0002882 μM. |
SANGER |
SK-MEL-2 |
Growth inhibition assay |
|
|
|
Inhibition of human SK-MEL-2 cell growth in a cell viability assay, IC50 = 0.0002947 μM. |
SANGER |
SW1990 |
Growth inhibition assay |
|
|
|
Inhibition of human SW1990 cell growth in a cell viability assay, IC50 = 0.000296 μM. |
SANGER |
ETK-1 |
Growth inhibition assay |
|
|
|
Inhibition of human ETK-1 cell growth in a cell viability assay, IC50 = 0.0002991 μM. |
SANGER |
TYK-nu |
Growth inhibition assay |
|
|
|
Inhibition of human TYK-nu cell growth in a cell viability assay, IC50 = 0.0003242 μM. |
SANGER |
U251 |
Growth inhibition assay |
|
|
|
Inhibition of human U251 cell growth in a cell viability assay, IC50 = 0.0003291 μM. |
SANGER |
SF295 |
Growth inhibition assay |
|
|
|
Inhibition of human SF295 cell growth in a cell viability assay, IC50 = 0.0003319 μM. |
SANGER |
CAL-39 |
Growth inhibition assay |
|
|
|
Inhibition of human CAL-39 cell growth in a cell viability assay, IC50 = 0.0003337 μM. |
SANGER |
KM-H2 |
Growth inhibition assay |
|
|
|
Inhibition of human KM-H2 cell growth in a cell viability assay, IC50 = 0.0003451 μM. |
SANGER |
NUGC-3 |
Growth inhibition assay |
|
|
|
Inhibition of human NUGC-3 cell growth in a cell viability assay, IC50 = 0.0003471 μM. |
SANGER |
KYSE-510 |
Growth inhibition assay |
|
|
|
Inhibition of human KYSE-510 cell growth in a cell viability assay, IC50 = 0.0003529 μM. |
SANGER |
SNU-423 |
Growth inhibition assay |
|
|
|
Inhibition of human SNU-423 cell growth in a cell viability assay, IC50 = 0.000392 μM. |
SANGER |
OVCAR-5 |
Growth inhibition assay |
|
|
|
Inhibition of human OVCAR-5 cell growth in a cell viability assay, IC50 = 0.0003985 μM. |
SANGER |
SNG-M |
Growth inhibition assay |
|
|
|
Inhibition of human SNG-M cell growth in a cell viability assay, IC50 = 0.000402 μM. |
SANGER |
SIG-M5 |
Growth inhibition assay |
|
|
|
Inhibition of human SIG-M5 cell growth in a cell viability assay, IC50 = 0.0004094 μM. |
SANGER |
NTERA-S-cl-D1 |
Growth inhibition assay |
|
|
|
Inhibition of human NTERA-S-cl-D1 cell growth in a cell viability assay, IC50 = 0.0004124 μM. |
SANGER |
SK-PN-DW |
Growth inhibition assay |
|
|
|
Inhibition of human SK-PN-DW cell growth in a cell viability assay, IC50 = 0.0004164 μM. |
SANGER |
697 |
Growth inhibition assay |
|
|
|
Inhibition of human 697 cell growth in a cell viability assay, IC50 = 0.0004253 μM. |
SANGER |
BCPAP |
Growth inhibition assay |
|
|
|
Inhibition of human BCPAP cell growth in a cell viability assay, IC50 = 0.000448 μM. |
SANGER |
SW982 |
Growth inhibition assay |
|
|
|
Inhibition of human SW982 cell growth in a cell viability assay, IC50 = 0.000472 μM. |
SANGER |
TGBC1TKB |
Growth inhibition assay |
|
|
|
Inhibition of human TGBC1TKB cell growth in a cell viability assay, IC50 = 0.0005092 μM. |
SANGER |
639-V |
Growth inhibition assay |
|
|
|
Inhibition of human 639-V cell growth in a cell viability assay, IC50 = 0.0005118 μM. |
SANGER |
KALS-1 |
Growth inhibition assay |
|
|
|
Inhibition of human KALS-1 cell growth in a cell viability assay, IC50 = 0.0005165 μM. |
SANGER |
HT-144 |
Growth inhibition assay |
|
|
|
Inhibition of human HT-144 cell growth in a cell viability assay, IC50 = 0.0005183 μM. |
SANGER |
NCI-H1792 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1792 cell growth in a cell viability assay, IC50 = 0.0005262 μM. |
SANGER |
NCI-H2087 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H2087 cell growth in a cell viability assay, IC50 = 0.0005461 μM. |
SANGER |
GI-1 |
Growth inhibition assay |
|
|
|
Inhibition of human GI-1 cell growth in a cell viability assay, IC50 = 0.0005493 μM. |
SANGER |
NCI-H1581 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1581 cell growth in a cell viability assay, IC50 = 0.0005498 μM. |
SANGER |
MDA-MB-231 |
Growth inhibition assay |
|
|
|
Inhibition of human MDA-MB-231 cell growth in a cell viability assay, IC50 = 0.0005573 μM. |
SANGER |
OCUB-M |
Growth inhibition assay |
|
|
|
Inhibition of human OCUB-M cell growth in a cell viability assay, IC50 = 0.0005967 μM. |
SANGER |
EW-16 |
Growth inhibition assay |
|
|
|
Inhibition of human EW-16 cell growth in a cell viability assay, IC50 = 0.0005984 μM. |
SANGER |
BPH-1 |
Growth inhibition assay |
|
|
|
Inhibition of human BPH-1 cell growth in a cell viability assay, IC50 = 0.0005996 μM. |
SANGER |
HOP-62 |
Growth inhibition assay |
|
|
|
Inhibition of human HOP-62 cell growth in a cell viability assay, IC50 = 0.0006013 μM. |
SANGER |
KY821 |
Growth inhibition assay |
|
|
|
Inhibition of human KY821 cell growth in a cell viability assay, IC50 = 0.000636 μM. |
SANGER |
HUTU-80 |
Growth inhibition assay |
|
|
|
Inhibition of human HUTU-80 cell growth in a cell viability assay, IC50 = 0.0006572 μM. |
SANGER |
BFTC-905 |
Growth inhibition assay |
|
|
|
Inhibition of human BFTC-905 cell growth in a cell viability assay, IC50 = 0.0006625 μM. |
SANGER |
PA-1 |
Growth inhibition assay |
|
|
|
Inhibition of human PA-1 cell growth in a cell viability assay, IC50 = 0.0006981 μM. |
SANGER |
T98G |
Growth inhibition assay |
|
|
|
Inhibition of human T98G cell growth in a cell viability assay, IC50 = 0.0007406 μM. |
SANGER |
COR-L23 |
Growth inhibition assay |
|
|
|
Inhibition of human COR-L23 cell growth in a cell viability assay, IC50 = 0.0007493 μM. |
SANGER |
KYSE-450 |
Growth inhibition assay |
|
|
|
Inhibition of human KYSE-450 cell growth in a cell viability assay, IC50 = 0.0007766 μM. |
SANGER |
IST-MEL1 |
Growth inhibition assay |
|
|
|
Inhibition of human IST-MEL1 cell growth in a cell viability assay, IC50 = 0.0007876 μM. |
SANGER |
L-363 |
Growth inhibition assay |
|
|
|
Inhibition of human L-363 cell growth in a cell viability assay, IC50 = 0.0008325 μM. |
SANGER |
Ramos-2G6-4C10 |
Growth inhibition assay |
|
|
|
Inhibition of human Ramos-2G6-4C10 cell growth in a cell viability assay, IC50 = 0.0008546 μM. |
SANGER |
NB69 |
Growth inhibition assay |
|
|
|
Inhibition of human NB69 cell growth in a cell viability assay, IC50 = 0.0008731 μM. |
SANGER |
NCI-H1299 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1299 cell growth in a cell viability assay, IC50 = 0.000879 μM. |
SANGER |
HCC1937 |
Growth inhibition assay |
|
|
|
Inhibition of human HCC1937 cell growth in a cell viability assay, IC50 = 0.0009269 μM. |
SANGER |
HCT-116 |
Growth inhibition assay |
|
|
|
Inhibition of human HCT-116 cell growth in a cell viability assay, IC50 = 0.0009429 μM. |
SANGER |
BFTC-909 |
Growth inhibition assay |
|
|
|
Inhibition of human BFTC-909 cell growth in a cell viability assay, IC50 = 0.0009681 μM. |
SANGER |
CAL-51 |
Growth inhibition assay |
|
|
|
Inhibition of human CAL-51 cell growth in a cell viability assay, IC50 = 0.0009713 μM. |
SANGER |
BB30-HNC |
Growth inhibition assay |
|
|
|
Inhibition of human BB30-HNC cell growth in a cell viability assay, IC50 = 0.0009842 μM. |
SANGER |
SCC-15 |
Growth inhibition assay |
|
|
|
Inhibition of human SCC-15 cell growth in a cell viability assay, IC50 = 0.001121 μM. |
SANGER |
NCI-H2405 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H2405 cell growth in a cell viability assay, IC50 = 0.001144 μM. |
SANGER |
SK-LU-1 |
Growth inhibition assay |
|
|
|
Inhibition of human SK-LU-1 cell growth in a cell viability assay, IC50 = 0.001159 μM. |
SANGER |
KYSE-180 |
Growth inhibition assay |
|
|
|
Inhibition of human KYSE-180 cell growth in a cell viability assay, IC50 = 0.001164 μM. |
SANGER |
22RV1 |
Growth inhibition assay |
|
|
|
Inhibition of human 22RV1 cell growth in a cell viability assay, IC50 = 0.001171 μM. |
SANGER |
AU565 |
Growth inhibition assay |
|
|
|
Inhibition of human AU565 cell growth in a cell viability assay, IC50 = 0.001202 μM. |
SANGER |
UM-UC-3 |
Growth inhibition assay |
|
|
|
Inhibition of human UM-UC-3 cell growth in a cell viability assay, IC50 = 0.001213 μM. |
SANGER |
RS4-11 |
Growth inhibition assay |
|
|
|
Inhibition of human RS4-11 cell growth in a cell viability assay, IC50 = 0.001297 μM. |
SANGER |
HuP-T4 |
Growth inhibition assay |
|
|
|
Inhibition of human HuP-T4 cell growth in a cell viability assay, IC50 = 0.001305 μM. |
SANGER |
MFH-ino |
Growth inhibition assay |
|
|
|
Inhibition of human MFH-ino cell growth in a cell viability assay, IC50 = 0.001323 μM. |
SANGER |
LU-99A |
Growth inhibition assay |
|
|
|
Inhibition of human LU-99A cell growth in a cell viability assay, IC50 = 0.001356 μM. |
SANGER |
HCC38 |
Growth inhibition assay |
|
|
|
Inhibition of human HCC38 cell growth in a cell viability assay, IC50 = 0.001367 μM. |
SANGER |
RERF-LC-MS |
Growth inhibition assay |
|
|
|
Inhibition of human RERF-LC-MS cell growth in a cell viability assay, IC50 = 0.001368 μM. |
SANGER |
TE-8 |
Growth inhibition assay |
|
|
|
Inhibition of human TE-8 cell growth in a cell viability assay, IC50 = 0.00137 μM. |
SANGER |
A388 |
Growth inhibition assay |
|
|
|
Inhibition of human A388 cell growth in a cell viability assay, IC50 = 0.001388 μM. |
SANGER |
NCI-H1648 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1648 cell growth in a cell viability assay, IC50 = 0.001436 μM. |
SANGER |
LK-2 |
Growth inhibition assay |
|
|
|
Inhibition of human LK-2 cell growth in a cell viability assay, IC50 = 0.001459 μM. |
SANGER |
NCI-H1734 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1734 cell growth in a cell viability assay, IC50 = 0.001481 μM. |
SANGER |
KYSE-270 |
Growth inhibition assay |
|
|
|
Inhibition of human KYSE-270 cell growth in a cell viability assay, IC50 = 0.001488 μM. |
SANGER |
TE-10 |
Growth inhibition assay |
|
|
|
Inhibition of human TE-10 cell growth in a cell viability assay, IC50 = 0.001573 μM. |
SANGER |
RKO |
Growth inhibition assay |
|
|
|
Inhibition of human RKO cell growth in a cell viability assay, IC50 = 0.00161 μM. |
SANGER |
NCI-H1573 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1573 cell growth in a cell viability assay, IC50 = 0.001622 μM. |
SANGER |
NCI-H2009 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H2009 cell growth in a cell viability assay, IC50 = 0.001635 μM. |
SANGER |
SW837 |
Growth inhibition assay |
|
|
|
Inhibition of human SW837 cell growth in a cell viability assay, IC50 = 0.001661 μM. |
SANGER |
SW48 |
Growth inhibition assay |
|
|
|
Inhibition of human SW48 cell growth in a cell viability assay, IC50 = 0.001669 μM. |
SANGER |
SCLC-21H |
Growth inhibition assay |
|
|
|
Inhibition of human SCLC-21H cell growth in a cell viability assay, IC50 = 0.00169 μM. |
SANGER |
A253 |
Growth inhibition assay |
|
|
|
Inhibition of human A253 cell growth in a cell viability assay, IC50 = 0.001728 μM. |
SANGER |
ST486 |
Growth inhibition assay |
|
|
|
Inhibition of human ST486 cell growth in a cell viability assay, IC50 = 0.001767 μM. |
SANGER |
MZ2-MEL |
Growth inhibition assay |
|
|
|
Inhibition of human MZ2-MEL cell growth in a cell viability assay, IC50 = 0.001793 μM. |
SANGER |
MEL-HO |
Growth inhibition assay |
|
|
|
Inhibition of human MEL-HO cell growth in a cell viability assay, IC50 = 0.001897 μM. |
SANGER |
SF539 |
Growth inhibition assay |
|
|
|
Inhibition of human SF539 cell growth in a cell viability assay, IC50 = 0.001945 μM. |
SANGER |
HOS |
Growth inhibition assay |
|
|
|
Inhibition of human HOS cell growth in a cell viability assay, IC50 = 0.001957 μM. |
SANGER |
A3-KAW |
Growth inhibition assay |
|
|
|
Inhibition of human A3-KAW cell growth in a cell viability assay, IC50 = 0.001982 μM. |
SANGER |
H4 |
Growth inhibition assay |
|
|
|
Inhibition of human H4 cell growth in a cell viability assay, IC50 = 0.001982 μM. |
SANGER |
8-MG-BA |
Growth inhibition assay |
|
|
|
Inhibition of human 8-MG-BA cell growth in a cell viability assay, IC50 = 0.001995 μM. |
SANGER |
HCC1143 |
Growth inhibition assay |
|
|
|
Inhibition of human HCC1143 cell growth in a cell viability assay, IC50 = 0.002072 μM. |
SANGER |
P30-OHK |
Growth inhibition assay |
|
|
|
Inhibition of human P30-OHK cell growth in a cell viability assay, IC50 = 0.00208 μM. |
SANGER |
Calu-1 |
Growth inhibition assay |
|
|
|
Inhibition of human Calu-1 cell growth in a cell viability assay, IC50 = 0.0021 μM. |
SANGER |
EW-18 |
Growth inhibition assay |
|
|
|
Inhibition of human EW-18 cell growth in a cell viability assay, IC50 = 0.002112 μM. |
SANGER |
KU812 |
Growth inhibition assay |
|
|
|
Inhibition of human KU812 cell growth in a cell viability assay, IC50 = 0.002118 μM. |
SANGER |
A427 |
Growth inhibition assay |
|
|
|
Inhibition of human A427 cell growth in a cell viability assay, IC50 = 0.002124 μM. |
SANGER |
SNU-387 |
Growth inhibition assay |
|
|
|
Inhibition of human SNU-387 cell growth in a cell viability assay, IC50 = 0.002201 μM. |
SANGER |
SF268 |
Growth inhibition assay |
|
|
|
Inhibition of human SF268 cell growth in a cell viability assay, IC50 = 0.002258 μM. |
SANGER |
BHY |
Growth inhibition assay |
|
|
|
Inhibition of human BHY cell growth in a cell viability assay, IC50 = 0.002258 μM. |
SANGER |
CAL-72 |
Growth inhibition assay |
|
|
|
Inhibition of human CAL-72 cell growth in a cell viability assay, IC50 = 0.002274 μM. |
SANGER |
EW-13 |
Growth inhibition assay |
|
|
|
Inhibition of human EW-13 cell growth in a cell viability assay, IC50 = 0.002309 μM. |
SANGER |
IA-LM |
Growth inhibition assay |
|
|
|
Inhibition of human IA-LM cell growth in a cell viability assay, IC50 = 0.002386 μM. |
SANGER |
HCC1806 |
Growth inhibition assay |
|
|
|
Inhibition of human HCC1806 cell growth in a cell viability assay, IC50 = 0.002403 μM. |
SANGER |
NCI-H226 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H226 cell growth in a cell viability assay, IC50 = 0.002412 μM. |
SANGER |
NCI-H1437 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1437 cell growth in a cell viability assay, IC50 = 0.002465 μM. |
SANGER |
Detroit562 |
Growth inhibition assay |
|
|
|
Inhibition of human Detroit562 cell growth in a cell viability assay, IC50 = 0.002517 μM. |
SANGER |
DB |
Growth inhibition assay |
|
|
|
Inhibition of human DB cell growth in a cell viability assay, IC50 = 0.002553 μM. |
SANGER |
SK-OV-3 |
Growth inhibition assay |
|
|
|
Inhibition of human SK-OV-3 cell growth in a cell viability assay, IC50 = 0.002638 μM. |
SANGER |
KP-4 |
Growth inhibition assay |
|
|
|
Inhibition of human KP-4 cell growth in a cell viability assay, IC50 = 0.002641 μM. |
SANGER |
A2058 |
Growth inhibition assay |
|
|
|
Inhibition of human A2058 cell growth in a cell viability assay, IC50 = 0.002691 μM. |
SANGER |
8305C |
Growth inhibition assay |
|
|
|
Inhibition of human 8305C cell growth in a cell viability assay, IC50 = 0.0027 μM. |
SANGER |
RPMI-2650 |
Growth inhibition assay |
|
|
|
Inhibition of human RPMI-2650 cell growth in a cell viability assay, IC50 = 0.00274 μM. |
SANGER |
HT-1376 |
Growth inhibition assay |
|
|
|
Inhibition of human HT-1376 cell growth in a cell viability assay, IC50 = 0.002748 μM. |
SANGER |
HLE |
Growth inhibition assay |
|
|
|
Inhibition of human HLE cell growth in a cell viability assay, IC50 = 0.002754 μM. |
SANGER |
MG-63 |
Growth inhibition assay |
|
|
|
Inhibition of human MG-63 cell growth in a cell viability assay, IC50 = 0.002791 μM. |
SANGER |
BV-173 |
Growth inhibition assay |
|
|
|
Inhibition of human BV-173 cell growth in a cell viability assay, IC50 = 0.002807 μM. |
SANGER |
U-266 |
Growth inhibition assay |
|
|
|
Inhibition of human U-266 cell growth in a cell viability assay, IC50 = 0.002912 μM. |
SANGER |
OVCAR-4 |
Growth inhibition assay |
|
|
|
Inhibition of human OVCAR-4 cell growth in a cell viability assay, IC50 = 0.002928 μM. |
SANGER |
MFE-296 |
Growth inhibition assay |
|
|
|
Inhibition of human MFE-296 cell growth in a cell viability assay, IC50 = 0.002946 μM. |
SANGER |
LOXIMVI |
Growth inhibition assay |
|
|
|
Inhibition of human LOXIMVI cell growth in a cell viability assay, IC50 = 0.002983 μM. |
SANGER |
CA46 |
Growth inhibition assay |
|
|
|
Inhibition of human CA46 cell growth in a cell viability assay, IC50 = 0.002985 μM. |
SANGER |
HSC-2 |
Growth inhibition assay |
|
|
|
Inhibition of human HSC-2 cell growth in a cell viability assay, IC50 = 0.002986 μM. |
SANGER |
CHP-212 |
Growth inhibition assay |
|
|
|
Inhibition of human CHP-212 cell growth in a cell viability assay, IC50 = 0.003001 μM. |
SANGER |
SJSA-1 |
Growth inhibition assay |
|
|
|
Inhibition of human SJSA-1 cell growth in a cell viability assay, IC50 = 0.003005 μM. |
SANGER |
SW620 |
Growth inhibition assay |
|
|
|
Inhibition of human SW620 cell growth in a cell viability assay, IC50 = 0.003022 μM. |
SANGER |
HCC1395 |
Growth inhibition assay |
|
|
|
Inhibition of human HCC1395 cell growth in a cell viability assay, IC50 = 0.00315 μM. |
SANGER |
COLO-205 |
Growth inhibition assay |
|
|
|
Inhibition of human COLO-205 cell growth in a cell viability assay, IC50 = 0.003153 μM. |
SANGER |
ABC-1 |
Growth inhibition assay |
|
|
|
Inhibition of human ABC-1 cell growth in a cell viability assay, IC50 = 0.003192 μM. |
SANGER |
SK-MEL-30 |
Growth inhibition assay |
|
|
|
Inhibition of human SK-MEL-30 cell growth in a cell viability assay, IC50 = 0.003244 μM. |
SANGER |
ChaGo-K-1 |
Growth inhibition assay |
|
|
|
Inhibition of human ChaGo-K-1 cell growth in a cell viability assay, IC50 = 0.003289 μM. |
SANGER |
MIA-PaCa-2 |
Growth inhibition assay |
|
|
|
Inhibition of human MIA-PaCa-2 cell growth in a cell viability assay, IC50 = 0.003297 μM. |
SANGER |
HCC2157 |
Growth inhibition assay |
|
|
|
Inhibition of human HCC2157 cell growth in a cell viability assay, IC50 = 0.003487 μM. |
SANGER |
CP66-MEL |
Growth inhibition assay |
|
|
|
Inhibition of human CP66-MEL cell growth in a cell viability assay, IC50 = 0.003596 μM. |
SANGER |
KS-1 |
Growth inhibition assay |
|
|
|
Inhibition of human KS-1 cell growth in a cell viability assay, IC50 = 0.003615 μM. |
SANGER |
Daudi |
Growth inhibition assay |
|
|
|
Inhibition of human Daudi cell growth in a cell viability assay, IC50 = 0.003633 μM. |
SANGER |
RVH-421 |
Growth inhibition assay |
|
|
|
Inhibition of human RVH-421 cell growth in a cell viability assay, IC50 = 0.003666 μM. |
SANGER |
RT4 |
Growth inhibition assay |
|
|
|
Inhibition of human RT4 cell growth in a cell viability assay, IC50 = 0.003736 μM. |
SANGER |
MONO-MAC-6 |
Growth inhibition assay |
|
|
|
Inhibition of human MONO-MAC-6 cell growth in a cell viability assay, IC50 = 0.003801 μM. |
SANGER |
EW-1 |
Growth inhibition assay |
|
|
|
Inhibition of human EW-1 cell growth in a cell viability assay, IC50 = 0.003882 μM. |
SANGER |
LB831-BLC |
Growth inhibition assay |
|
|
|
Inhibition of human LB831-BLC cell growth in a cell viability assay, IC50 = 0.003945 μM. |
SANGER |
G-402 |
Growth inhibition assay |
|
|
|
Inhibition of human G-402 cell growth in a cell viability assay, IC50 = 0.003953 μM. |
SANGER |
RPMI-7951 |
Growth inhibition assay |
|
|
|
Inhibition of human RPMI-7951 cell growth in a cell viability assay, IC50 = 0.003976 μM. |
SANGER |
MDA-MB-468 |
Growth inhibition assay |
|
|
|
Inhibition of human MDA-MB-468 cell growth in a cell viability assay, IC50 = 0.003983 μM. |
SANGER |
NCI-H2030 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H2030 cell growth in a cell viability assay, IC50 = 0.004048 μM. |
SANGER |
LP-1 |
Growth inhibition assay |
|
|
|
Inhibition of human LP-1 cell growth in a cell viability assay, IC50 = 0.004083 μM. |
SANGER |
ES3 |
Growth inhibition assay |
|
|
|
Inhibition of human ES3 cell growth in a cell viability assay, IC50 = 0.004103 μM. |
SANGER |
A431 |
Growth inhibition assay |
|
|
|
Inhibition of human A431 cell growth in a cell viability assay, IC50 = 0.004113 μM. |
SANGER |
SNU-449 |
Growth inhibition assay |
|
|
|
Inhibition of human SNU-449 cell growth in a cell viability assay, IC50 = 0.004178 μM. |
SANGER |
MHH-ES-1 |
Growth inhibition assay |
|
|
|
Inhibition of human MHH-ES-1 cell growth in a cell viability assay, IC50 = 0.004184 μM. |
SANGER |
LC-1F |
Growth inhibition assay |
|
|
|
Inhibition of human LC-1F cell growth in a cell viability assay, IC50 = 0.004194 μM. |
SANGER |
RT-112 |
Growth inhibition assay |
|
|
|
Inhibition of human RT-112 cell growth in a cell viability assay, IC50 = 0.004217 μM. |
SANGER |
HCE-4 |
Growth inhibition assay |
|
|
|
Inhibition of human HCE-4 cell growth in a cell viability assay, IC50 = 0.004245 μM. |
SANGER |
HuCCT1 |
Growth inhibition assay |
|
|
|
Inhibition of human HuCCT1 cell growth in a cell viability assay, IC50 = 0.004328 μM. |
SANGER |
NCI-H2122 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H2122 cell growth in a cell viability assay, IC50 = 0.004494 μM. |
SANGER |
BC-3 |
Growth inhibition assay |
|
|
|
Inhibition of human BC-3 cell growth in a cell viability assay, IC50 = 0.004511 μM. |
SANGER |
MOLT-16 |
Growth inhibition assay |
|
|
|
Inhibition of human MOLT-16 cell growth in a cell viability assay, IC50 = 0.004524 μM. |
SANGER |
NB6 |
Growth inhibition assay |
|
|
|
Inhibition of human NB6 cell growth in a cell viability assay, IC50 = 0.004576 μM. |
SANGER |
LC-2-ad |
Growth inhibition assay |
|
|
|
Inhibition of human LC-2-ad cell growth in a cell viability assay, IC50 = 0.00464 μM. |
SANGER |
ACN |
Growth inhibition assay |
|
|
|
Inhibition of human ACN cell growth in a cell viability assay, IC50 = 0.00469 μM. |
SANGER |
MDA-MB-361 |
Growth inhibition assay |
|
|
|
Inhibition of human MDA-MB-361 cell growth in a cell viability assay, IC50 = 0.004729 μM. |
SANGER |
TGW |
Growth inhibition assay |
|
|
|
Inhibition of human TGW cell growth in a cell viability assay, IC50 = 0.004732 μM. |
SANGER |
Calu-6 |
Growth inhibition assay |
|
|
|
Inhibition of human Calu-6 cell growth in a cell viability assay, IC50 = 0.004785 μM. |
SANGER |
A101D |
Growth inhibition assay |
|
|
|
Inhibition of human A101D cell growth in a cell viability assay, IC50 = 0.004818 μM. |
SANGER |
LB647-SCLC |
Growth inhibition assay |
|
|
|
Inhibition of human LB647-SCLC cell growth in a cell viability assay, IC50 = 0.004861 μM. |
SANGER |
TE-15 |
Growth inhibition assay |
|
|
|
Inhibition of human TE-15 cell growth in a cell viability assay, IC50 = 0.004912 μM. |
SANGER |
BB65-RCC |
Growth inhibition assay |
|
|
|
Inhibition of human BB65-RCC cell growth in a cell viability assay, IC50 = 0.00508 μM. |
SANGER |
CTV-1 |
Growth inhibition assay |
|
|
|
Inhibition of human CTV-1 cell growth in a cell viability assay, IC50 = 0.005196 μM. |
SANGER |
RPMI-8402 |
Growth inhibition assay |
|
|
|
Inhibition of human RPMI-8402 cell growth in a cell viability assay, IC50 = 0.005227 μM. |
SANGER |
HOP-92 |
Growth inhibition assay |
|
|
|
Inhibition of human HOP-92 cell growth in a cell viability assay, IC50 = 0.005258 μM. |
SANGER |
GCT |
Growth inhibition assay |
|
|
|
Inhibition of human GCT cell growth in a cell viability assay, IC50 = 0.005303 μM. |
SANGER |
Daoy |
Growth inhibition assay |
|
|
|
Inhibition of human Daoy cell growth in a cell viability assay, IC50 = 0.005343 μM. |
SANGER |
HT-29 |
Growth inhibition assay |
|
|
|
Inhibition of human HT-29 cell growth in a cell viability assay, IC50 = 0.005405 μM. |
SANGER |
NCI-H522 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H522 cell growth in a cell viability assay, IC50 = 0.00543 μM. |
SANGER |
KURAMOCHI |
Growth inhibition assay |
|
|
|
Inhibition of human KURAMOCHI cell growth in a cell viability assay, IC50 = 0.005444 μM. |
SANGER |
NCI-H1355 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1355 cell growth in a cell viability assay, IC50 = 0.005482 μM. |
SANGER |
WSU-NHL |
Growth inhibition assay |
|
|
|
Inhibition of human WSU-NHL cell growth in a cell viability assay, IC50 = 0.005539 μM. |
SANGER |
HT |
Growth inhibition assay |
|
|
|
Inhibition of human HT cell growth in a cell viability assay, IC50 = 0.0057 μM. |
SANGER |
SW872 |
Growth inhibition assay |
|
|
|
Inhibition of human SW872 cell growth in a cell viability assay, IC50 = 0.005776 μM. |
SANGER |
DU-4475 |
Growth inhibition assay |
|
|
|
Inhibition of human DU-4475 cell growth in a cell viability assay, IC50 = 0.005967 μM. |
SANGER |
CAL-85-1 |
Growth inhibition assay |
|
|
|
Inhibition of human CAL-85-1 cell growth in a cell viability assay, IC50 = 0.006035 μM. |
SANGER |
NKM-1 |
Growth inhibition assay |
|
|
|
Inhibition of human NKM-1 cell growth in a cell viability assay, IC50 = 0.006119 μM. |
SANGER |
LS-123 |
Growth inhibition assay |
|
|
|
Inhibition of human LS-123 cell growth in a cell viability assay, IC50 = 0.00623 μM. |
SANGER |
EW-7 |
Growth inhibition assay |
|
|
|
Inhibition of human EW-7 cell growth in a cell viability assay, IC50 = 0.006345 μM. |
SANGER |
REH |
Growth inhibition assay |
|
|
|
Inhibition of human REH cell growth in a cell viability assay, IC50 = 0.00639 μM. |
SANGER |
NCI-H2052 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H2052 cell growth in a cell viability assay, IC50 = 0.006402 μM. |
SANGER |
NCI-H64 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H64 cell growth in a cell viability assay, IC50 = 0.006454 μM. |
SANGER |
SK-MEL-3 |
Growth inhibition assay |
|
|
|
Inhibition of human SK-MEL-3 cell growth in a cell viability assay, IC50 = 0.006514 μM. |
SANGER |
BxPC-3 |
Growth inhibition assay |
|
|
|
Inhibition of human BxPC-3 cell growth in a cell viability assay, IC50 = 0.00653 μM. |
SANGER |
IPC-298 |
Growth inhibition assay |
|
|
|
Inhibition of human IPC-298 cell growth in a cell viability assay, IC50 = 0.006538 μM. |
SANGER |
IST-SL2 |
Growth inhibition assay |
|
|
|
Inhibition of human IST-SL2 cell growth in a cell viability assay, IC50 = 0.006764 μM. |
SANGER |
SW962 |
Growth inhibition assay |
|
|
|
Inhibition of human SW962 cell growth in a cell viability assay, IC50 = 0.006848 μM. |
SANGER |
HMV-II |
Growth inhibition assay |
|
|
|
Inhibition of human HMV-II cell growth in a cell viability assay, IC50 = 0.006873 μM. |
SANGER |
D-542MG |
Growth inhibition assay |
|
|
|
Inhibition of human D-542MG cell growth in a cell viability assay, IC50 = 0.006929 μM. |
SANGER |
LB1047-RCC |
Growth inhibition assay |
|
|
|
Inhibition of human LB1047-RCC cell growth in a cell viability assay, IC50 = 0.007047 μM. |
SANGER |
NCI-H810 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H810 cell growth in a cell viability assay, IC50 = 0.00714 μM. |
SANGER |
JiyoyeP-2003 |
Growth inhibition assay |
|
|
|
Inhibition of human JiyoyeP-2003 cell growth in a cell viability assay, IC50 = 0.007207 μM. |
SANGER |
A673 |
Growth inhibition assay |
|
|
|
Inhibition of human A673 cell growth in a cell viability assay, IC50 = 0.007237 μM. |
SANGER |
RD |
Growth inhibition assay |
|
|
|
Inhibition of human RD cell growth in a cell viability assay, IC50 = 0.007346 μM. |
SANGER |
BE-13 |
Growth inhibition assay |
|
|
|
Inhibition of human BE-13 cell growth in a cell viability assay, IC50 = 0.00735 μM. |
SANGER |
KE-37 |
Growth inhibition assay |
|
|
|
Inhibition of human KE-37 cell growth in a cell viability assay, IC50 = 0.007531 μM. |
SANGER |
ESS-1 |
Growth inhibition assay |
|
|
|
Inhibition of human ESS-1 cell growth in a cell viability assay, IC50 = 0.007585 μM. |
SANGER |
KINGS-1 |
Growth inhibition assay |
|
|
|
Inhibition of human KINGS-1 cell growth in a cell viability assay, IC50 = 0.007588 μM. |
SANGER |
YKG-1 |
Growth inhibition assay |
|
|
|
Inhibition of human YKG-1 cell growth in a cell viability assay, IC50 = 0.007718 μM. |
SANGER |
SK-HEP-1 |
Growth inhibition assay |
|
|
|
Inhibition of human SK-HEP-1 cell growth in a cell viability assay, IC50 = 0.007803 μM. |
SANGER |
J82 |
Growth inhibition assay |
|
|
|
Inhibition of human J82 cell growth in a cell viability assay, IC50 = 0.00791 μM. |
SANGER |
PC-3 |
Growth inhibition assay |
|
|
|
Inhibition of human PC-3 cell growth in a cell viability assay, IC50 = 0.008002 μM. |
SANGER |
NCI-H2228 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H2228 cell growth in a cell viability assay, IC50 = 0.008004 μM. |
SANGER |
PC-14 |
Growth inhibition assay |
|
|
|
Inhibition of human PC-14 cell growth in a cell viability assay, IC50 = 0.008013 μM. |
SANGER |
OCI-AML2 |
Growth inhibition assay |
|
|
|
Inhibition of human OCI-AML2 cell growth in a cell viability assay, IC50 = 0.008045 μM. |
SANGER |
KP-N-YS |
Growth inhibition assay |
|
|
|
Inhibition of human KP-N-YS cell growth in a cell viability assay, IC50 = 0.008056 μM. |
SANGER |
KARPAS-45 |
Growth inhibition assay |
|
|
|
Inhibition of human KARPAS-45 cell growth in a cell viability assay, IC50 = 0.008059 μM. |
SANGER |
SBC-5 |
Growth inhibition assay |
|
|
|
Inhibition of human SBC-5 cell growth in a cell viability assay, IC50 = 0.008083 μM. |
SANGER |
NCI-H727 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H727 cell growth in a cell viability assay, IC50 = 0.008364 μM. |
SANGER |
NCI-H460 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H460 cell growth in a cell viability assay, IC50 = 0.008369 μM. |
SANGER |
LU-65 |
Growth inhibition assay |
|
|
|
Inhibition of human LU-65 cell growth in a cell viability assay, IC50 = 0.008491 μM. |
SANGER |
CaR-1 |
Growth inhibition assay |
|
|
|
Inhibition of human CaR-1 cell growth in a cell viability assay, IC50 = 0.008619 μM. |
SANGER |
DU-145 |
Growth inhibition assay |
|
|
|
Inhibition of human DU-145 cell growth in a cell viability assay, IC50 = 0.008629 μM. |
SANGER |
AGS |
Growth inhibition assay |
|
|
|
Inhibition of human AGS cell growth in a cell viability assay, IC50 = 0.008778 μM. |
SANGER |
BL-70 |
Growth inhibition assay |
|
|
|
Inhibition of human BL-70 cell growth in a cell viability assay, IC50 = 0.008818 μM. |
SANGER |
SJRH30 |
Growth inhibition assay |
|
|
|
Inhibition of human SJRH30 cell growth in a cell viability assay, IC50 = 0.008838 μM. |
SANGER |
GAMG |
Growth inhibition assay |
|
|
|
Inhibition of human GAMG cell growth in a cell viability assay, IC50 = 0.008864 μM. |
SANGER |
TE-11 |
Growth inhibition assay |
|
|
|
Inhibition of human TE-11 cell growth in a cell viability assay, IC50 = 0.009144 μM. |
SANGER |
UMC-11 |
Growth inhibition assay |
|
|
|
Inhibition of human UMC-11 cell growth in a cell viability assay, IC50 = 0.009147 μM. |
SANGER |
SW1783 |
Growth inhibition assay |
|
|
|
Inhibition of human SW1783 cell growth in a cell viability assay, IC50 = 0.009236 μM. |
SANGER |
SW13 |
Growth inhibition assay |
|
|
|
Inhibition of human SW13 cell growth in a cell viability assay, IC50 = 0.009382 μM. |
SANGER |
NB13 |
Growth inhibition assay |
|
|
|
Inhibition of human NB13 cell growth in a cell viability assay, IC50 = 0.009447 μM. |
SANGER |
SCC-25 |
Growth inhibition assay |
|
|
|
Inhibition of human SCC-25 cell growth in a cell viability assay, IC50 = 0.00971 μM. |
SANGER |
C-33-A |
Growth inhibition assay |
|
|
|
Inhibition of human C-33-A cell growth in a cell viability assay, IC50 = 0.009775 μM. |
SANGER |
JEG-3 |
Growth inhibition assay |
|
|
|
Inhibition of human JEG-3 cell growth in a cell viability assay, IC50 = 0.009779 μM. |
SANGER |
MKN28 |
Growth inhibition assay |
|
|
|
Inhibition of human MKN28 cell growth in a cell viability assay, IC50 = 0.00979 μM. |
SANGER |
ONS-76 |
Growth inhibition assay |
|
|
|
Inhibition of human ONS-76 cell growth in a cell viability assay, IC50 = 0.009981 μM. |
SANGER |
CPC-N |
Growth inhibition assay |
|
|
|
Inhibition of human CPC-N cell growth in a cell viability assay, IC50 = 0.01003 μM. |
SANGER |
NCI-H1618 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1618 cell growth in a cell viability assay, IC50 = 0.0101 μM. |
SANGER |
NCI-H1703 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1703 cell growth in a cell viability assay, IC50 = 0.01014 μM. |
SANGER |
NCI-H2347 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H2347 cell growth in a cell viability assay, IC50 = 0.01023 μM. |
SANGER |
DEL |
Growth inhibition assay |
|
|
|
Inhibition of human DEL cell growth in a cell viability assay, IC50 = 0.01034 μM. |
SANGER |
SCC-4 |
Growth inhibition assay |
|
|
|
Inhibition of human SCC-4 cell growth in a cell viability assay, IC50 = 0.01037 μM. |
SANGER |
EB2 |
Growth inhibition assay |
|
|
|
Inhibition of human EB2 cell growth in a cell viability assay, IC50 = 0.01043 μM. |
SANGER |
LoVo |
Growth inhibition assay |
|
|
|
Inhibition of human LoVo cell growth in a cell viability assay, IC50 = 0.01044 μM. |
SANGER |
CAMA-1 |
Growth inhibition assay |
|
|
|
Inhibition of human CAMA-1 cell growth in a cell viability assay, IC50 = 0.01045 μM. |
SANGER |
GR-ST |
Growth inhibition assay |
|
|
|
Inhibition of human GR-ST cell growth in a cell viability assay, IC50 = 0.0105 μM. |
SANGER |
IGR-1 |
Growth inhibition assay |
|
|
|
Inhibition of human IGR-1 cell growth in a cell viability assay, IC50 = 0.01051 μM. |
SANGER |
TE-12 |
Growth inhibition assay |
|
|
|
Inhibition of human TE-12 cell growth in a cell viability assay, IC50 = 0.01059 μM. |
SANGER |
G-361 |
Growth inhibition assay |
|
|
|
Inhibition of human G-361 cell growth in a cell viability assay, IC50 = 0.01067 μM. |
SANGER |
M059J |
Growth inhibition assay |
|
|
|
Inhibition of human M059J cell growth in a cell viability assay, IC50 = 0.01078 μM. |
SANGER |
MEG-01 |
Growth inhibition assay |
|
|
|
Inhibition of human MEG-01 cell growth in a cell viability assay, IC50 = 0.01078 μM. |
SANGER |
COLO-741 |
Growth inhibition assay |
|
|
|
Inhibition of human COLO-741 cell growth in a cell viability assay, IC50 = 0.01089 μM. |
SANGER |
MV-4-11 |
Growth inhibition assay |
|
|
|
Inhibition of human MV-4-11 cell growth in a cell viability assay, IC50 = 0.01098 μM. |
SANGER |
NEC8 |
Growth inhibition assay |
|
|
|
Inhibition of human NEC8 cell growth in a cell viability assay, IC50 = 0.011 μM. |
SANGER |
CP50-MEL-B |
Growth inhibition assay |
|
|
|
Inhibition of human CP50-MEL-B cell growth in a cell viability assay, IC50 = 0.0111 μM. |
SANGER |
VMRC-RCZ |
Growth inhibition assay |
|
|
|
Inhibition of human VMRC-RCZ cell growth in a cell viability assay, IC50 = 0.01119 μM. |
SANGER |
HSC-3 |
Growth inhibition assay |
|
|
|
Inhibition of human HSC-3 cell growth in a cell viability assay, IC50 = 0.01126 μM. |
SANGER |
5637 |
Growth inhibition assay |
|
|
|
Inhibition of human 5637 cell growth in a cell viability assay, IC50 = 0.01142 μM. |
SANGER |
THP-1 |
Growth inhibition assay |
|
|
|
Inhibition of human THP-1 cell growth in a cell viability assay, IC50 = 0.01144 μM. |
SANGER |
COR-L105 |
Growth inhibition assay |
|
|
|
Inhibition of human COR-L105 cell growth in a cell viability assay, IC50 = 0.01155 μM. |
SANGER |
DBTRG-05MG |
Growth inhibition assay |
|
|
|
Inhibition of human DBTRG-05MG cell growth in a cell viability assay, IC50 = 0.01175 μM. |
SANGER |
GT3TKB |
Growth inhibition assay |
|
|
|
Inhibition of human GT3TKB cell growth in a cell viability assay, IC50 = 0.01222 μM. |
SANGER |
T-24 |
Growth inhibition assay |
|
|
|
Inhibition of human T-24 cell growth in a cell viability assay, IC50 = 0.01227 μM. |
SANGER |
DoTc2-4510 |
Growth inhibition assay |
|
|
|
Inhibition of human DoTc2-4510 cell growth in a cell viability assay, IC50 = 0.01239 μM. |
SANGER |
SNU-C2B |
Growth inhibition assay |
|
|
|
Inhibition of human SNU-C2B cell growth in a cell viability assay, IC50 = 0.01243 μM. |
SANGER |
CHL-1 |
Growth inhibition assay |
|
|
|
Inhibition of human CHL-1 cell growth in a cell viability assay, IC50 = 0.01249 μM. |
SANGER |
TUR |
Growth inhibition assay |
|
|
|
Inhibition of human TUR cell growth in a cell viability assay, IC50 = 0.01251 μM. |
SANGER |
NCI-H2171 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H2171 cell growth in a cell viability assay, IC50 = 0.01255 μM. |
SANGER |
NCI-H441 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H441 cell growth in a cell viability assay, IC50 = 0.01255 μM. |
SANGER |
MHH-PREB-1 |
Growth inhibition assay |
|
|
|
Inhibition of human MHH-PREB-1 cell growth in a cell viability assay, IC50 = 0.01263 μM. |
SANGER |
SW756 |
Growth inhibition assay |
|
|
|
Inhibition of human SW756 cell growth in a cell viability assay, IC50 = 0.01275 μM. |
SANGER |
PFSK-1 |
Growth inhibition assay |
|
|
|
Inhibition of human PFSK-1 cell growth in a cell viability assay, IC50 = 0.01277 μM. |
SANGER |
YT |
Growth inhibition assay |
|
|
|
Inhibition of human YT cell growth in a cell viability assay, IC50 = 0.0131 μM. |
SANGER |
NB12 |
Growth inhibition assay |
|
|
|
Inhibition of human NB12 cell growth in a cell viability assay, IC50 = 0.0132 μM. |
SANGER |
TE-9 |
Growth inhibition assay |
|
|
|
Inhibition of human TE-9 cell growth in a cell viability assay, IC50 = 0.01326 μM. |
SANGER |
RMG-I |
Growth inhibition assay |
|
|
|
Inhibition of human RMG-I cell growth in a cell viability assay, IC50 = 0.01333 μM. |
SANGER |
T84 |
Growth inhibition assay |
|
|
|
Inhibition of human T84 cell growth in a cell viability assay, IC50 = 0.01336 μM. |
SANGER |
KM12 |
Growth inhibition assay |
|
|
|
Inhibition of human KM12 cell growth in a cell viability assay, IC50 = 0.01344 μM. |
SANGER |
CAPAN-1 |
Growth inhibition assay |
|
|
|
Inhibition of human CAPAN-1 cell growth in a cell viability assay, IC50 = 0.01346 μM. |
SANGER |
NCI-SNU-1 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-SNU-1 cell growth in a cell viability assay, IC50 = 0.01359 μM. |
SANGER |
LS-411N |
Growth inhibition assay |
|
|
|
Inhibition of human LS-411N cell growth in a cell viability assay, IC50 = 0.01363 μM. |
SANGER |
647-V |
Growth inhibition assay |
|
|
|
Inhibition of human 647-V cell growth in a cell viability assay, IC50 = 0.01371 μM. |
SANGER |
DSH1 |
Growth inhibition assay |
|
|
|
Inhibition of human DSH1 cell growth in a cell viability assay, IC50 = 0.01389 μM. |
SANGER |
BEN |
Growth inhibition assay |
|
|
|
Inhibition of human BEN cell growth in a cell viability assay, IC50 = 0.0139 μM. |
SANGER |
M14 |
Growth inhibition assay |
|
|
|
Inhibition of human M14 cell growth in a cell viability assay, IC50 = 0.014 μM. |
SANGER |
NCI-H2170 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H2170 cell growth in a cell viability assay, IC50 = 0.0144 μM. |
SANGER |
Saos-2 |
Growth inhibition assay |
|
|
|
Inhibition of human Saos-2 cell growth in a cell viability assay, IC50 = 0.0147 μM. |
SANGER |
AM-38 |
Growth inhibition assay |
|
|
|
Inhibition of human AM-38 cell growth in a cell viability assay, IC50 = 0.01481 μM. |
SANGER |
RPMI-8226 |
Growth inhibition assay |
|
|
|
Inhibition of human RPMI-8226 cell growth in a cell viability assay, IC50 = 0.01486 μM. |
SANGER |
NCI-H292 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H292 cell growth in a cell viability assay, IC50 = 0.01493 μM. |
SANGER |
SW954 |
Growth inhibition assay |
|
|
|
Inhibition of human SW954 cell growth in a cell viability assay, IC50 = 0.01555 μM. |
SANGER |
IMR-5 |
Growth inhibition assay |
|
|
|
Inhibition of human IMR-5 cell growth in a cell viability assay, IC50 = 0.01555 μM. |
SANGER |
SK-NEP-1 |
Growth inhibition assay |
|
|
|
Inhibition of human SK-NEP-1 cell growth in a cell viability assay, IC50 = 0.01593 μM. |
SANGER |
ALL-PO |
Growth inhibition assay |
|
|
|
Inhibition of human ALL-PO cell growth in a cell viability assay, IC50 = 0.01626 μM. |
SANGER |
EFO-21 |
Growth inhibition assay |
|
|
|
Inhibition of human EFO-21 cell growth in a cell viability assay, IC50 = 0.01639 μM. |
SANGER |
SN12C |
Growth inhibition assay |
|
|
|
Inhibition of human SN12C cell growth in a cell viability assay, IC50 = 0.01659 μM. |
SANGER |
KNS-42 |
Growth inhibition assay |
|
|
|
Inhibition of human KNS-42 cell growth in a cell viability assay, IC50 = 0.01689 μM. |
SANGER |
CTB-1 |
Growth inhibition assay |
|
|
|
Inhibition of human CTB-1 cell growth in a cell viability assay, IC50 = 0.01697 μM. |
SANGER |
SK-CO-1 |
Growth inhibition assay |
|
|
|
Inhibition of human SK-CO-1 cell growth in a cell viability assay, IC50 = 0.01703 μM. |
SANGER |
A204 |
Growth inhibition assay |
|
|
|
Inhibition of human A204 cell growth in a cell viability assay, IC50 = 0.01729 μM. |
SANGER |
LB2518-MEL |
Growth inhibition assay |
|
|
|
Inhibition of human LB2518-MEL cell growth in a cell viability assay, IC50 = 0.01732 μM. |
SANGER |
HD-MY-Z |
Growth inhibition assay |
|
|
|
Inhibition of human HD-MY-Z cell growth in a cell viability assay, IC50 = 0.0175 μM. |
SANGER |
SW626 |
Growth inhibition assay |
|
|
|
Inhibition of human SW626 cell growth in a cell viability assay, IC50 = 0.01768 μM. |
SANGER |
SH-4 |
Growth inhibition assay |
|
|
|
Inhibition of human SH-4 cell growth in a cell viability assay, IC50 = 0.01777 μM. |
SANGER |
TE-6 |
Growth inhibition assay |
|
|
|
Inhibition of human TE-6 cell growth in a cell viability assay, IC50 = 0.01782 μM. |
SANGER |
HCC1569 |
Growth inhibition assay |
|
|
|
Inhibition of human HCC1569 cell growth in a cell viability assay, IC50 = 0.01791 μM. |
SANGER |
COLO-680N |
Growth inhibition assay |
|
|
|
Inhibition of human COLO-680N cell growth in a cell viability assay, IC50 = 0.01802 μM. |
SANGER |
HuP-T3 |
Growth inhibition assay |
|
|
|
Inhibition of human HuP-T3 cell growth in a cell viability assay, IC50 = 0.01808 μM. |
SANGER |
NCI-H209 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H209 cell growth in a cell viability assay, IC50 = 0.0181 μM. |
SANGER |
ES8 |
Growth inhibition assay |
|
|
|
Inhibition of human ES8 cell growth in a cell viability assay, IC50 = 0.0181 μM. |
SANGER |
VA-ES-BJ |
Growth inhibition assay |
|
|
|
Inhibition of human VA-ES-BJ cell growth in a cell viability assay, IC50 = 0.01817 μM. |
SANGER |
GI-ME-N |
Growth inhibition assay |
|
|
|
Inhibition of human GI-ME-N cell growth in a cell viability assay, IC50 = 0.01822 μM. |
SANGER |
EB-3 |
Growth inhibition assay |
|
|
|
Inhibition of human EB-3 cell growth in a cell viability assay, IC50 = 0.01896 μM. |
SANGER |
LAMA-84 |
Growth inhibition assay |
|
|
|
Inhibition of human LAMA-84 cell growth in a cell viability assay, IC50 = 0.01944 μM. |
SANGER |
COLO-668 |
Growth inhibition assay |
|
|
|
Inhibition of human COLO-668 cell growth in a cell viability assay, IC50 = 0.01968 μM. |
SANGER |
DMS-153 |
Growth inhibition assay |
|
|
|
Inhibition of human DMS-153 cell growth in a cell viability assay, IC50 = 0.01987 μM. |
SANGER |
NCI-H661 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H661 cell growth in a cell viability assay, IC50 = 0.01992 μM. |
SANGER |
MPP-89 |
Growth inhibition assay |
|
|
|
Inhibition of human MPP-89 cell growth in a cell viability assay, IC50 = 0.02005 μM. |
SANGER |
C-4-II |
Growth inhibition assay |
|
|
|
Inhibition of human C-4-II cell growth in a cell viability assay, IC50 = 0.02061 μM. |
SANGER |
KYSE-520 |
Growth inhibition assay |
|
|
|
Inhibition of human KYSE-520 cell growth in a cell viability assay, IC50 = 0.02074 μM. |
SANGER |
ES7 |
Growth inhibition assay |
|
|
|
Inhibition of human ES7 cell growth in a cell viability assay, IC50 = 0.02112 μM. |
SANGER |
NMC-G1 |
Growth inhibition assay |
|
|
|
Inhibition of human NMC-G1 cell growth in a cell viability assay, IC50 = 0.02147 μM. |
SANGER |
HTC-C3 |
Growth inhibition assay |
|
|
|
Inhibition of human HTC-C3 cell growth in a cell viability assay, IC50 = 0.02168 μM. |
SANGER |
TALL-1 |
Growth inhibition assay |
|
|
|
Inhibition of human TALL-1 cell growth in a cell viability assay, IC50 = 0.02169 μM. |
SANGER |
HT-3 |
Growth inhibition assay |
|
|
|
Inhibition of human HT-3 cell growth in a cell viability assay, IC50 = 0.02172 μM. |
SANGER |
EGI-1 |
Growth inhibition assay |
|
|
|
Inhibition of human EGI-1 cell growth in a cell viability assay, IC50 = 0.02174 μM. |
SANGER |
WM-115 |
Growth inhibition assay |
|
|
|
Inhibition of human WM-115 cell growth in a cell viability assay, IC50 = 0.02192 μM. |
SANGER |
TE-1 |
Growth inhibition assay |
|
|
|
Inhibition of human TE-1 cell growth in a cell viability assay, IC50 = 0.02199 μM. |
SANGER |
VM-CUB-1 |
Growth inhibition assay |
|
|
|
Inhibition of human VM-CUB-1 cell growth in a cell viability assay, IC50 = 0.02201 μM. |
SANGER |
KYSE-150 |
Growth inhibition assay |
|
|
|
Inhibition of human KYSE-150 cell growth in a cell viability assay, IC50 = 0.02219 μM. |
SANGER |
DOHH-2 |
Growth inhibition assay |
|
|
|
Inhibition of human DOHH-2 cell growth in a cell viability assay, IC50 = 0.02226 μM. |
SANGER |
HCC70 |
Growth inhibition assay |
|
|
|
Inhibition of human HCC70 cell growth in a cell viability assay, IC50 = 0.02262 μM. |
SANGER |
TK10 |
Growth inhibition assay |
|
|
|
Inhibition of human TK10 cell growth in a cell viability assay, IC50 = 0.02272 μM. |
SANGER |
Ca9-22 |
Growth inhibition assay |
|
|
|
Inhibition of human Ca9-22 cell growth in a cell viability assay, IC50 = 0.02278 μM. |
SANGER |
BC-1 |
Growth inhibition assay |
|
|
|
Inhibition of human BC-1 cell growth in a cell viability assay, IC50 = 0.02316 μM. |
SANGER |
MRK-nu-1 |
Growth inhibition assay |
|
|
|
Inhibition of human MRK-nu-1 cell growth in a cell viability assay, IC50 = 0.02322 μM. |
SANGER |
SK-UT-1 |
Growth inhibition assay |
|
|
|
Inhibition of human SK-UT-1 cell growth in a cell viability assay, IC50 = 0.02331 μM. |
SANGER |
PANC-08-13 |
Growth inhibition assay |
|
|
|
Inhibition of human PANC-08-13 cell growth in a cell viability assay, IC50 = 0.02381 μM. |
SANGER |
KARPAS-422 |
Growth inhibition assay |
|
|
|
Inhibition of human KARPAS-422 cell growth in a cell viability assay, IC50 = 0.02387 μM. |
SANGER |
NH-12 |
Growth inhibition assay |
|
|
|
Inhibition of human NH-12 cell growth in a cell viability assay, IC50 = 0.02402 μM. |
SANGER |
IST-SL1 |
Growth inhibition assay |
|
|
|
Inhibition of human IST-SL1 cell growth in a cell viability assay, IC50 = 0.02417 μM. |
SANGER |
EoL-1-cell |
Growth inhibition assay |
|
|
|
Inhibition of human EoL-1-cell cell growth in a cell viability assay, IC50 = 0.02418 μM. |
SANGER |
OS-RC-2 |
Growth inhibition assay |
|
|
|
Inhibition of human OS-RC-2 cell growth in a cell viability assay, IC50 = 0.02427 μM. |
SANGER |
MC-CAR |
Growth inhibition assay |
|
|
|
Inhibition of human MC-CAR cell growth in a cell viability assay, IC50 = 0.02442 μM. |
SANGER |
P12-ICHIKAWA |
Growth inhibition assay |
|
|
|
Inhibition of human P12-ICHIKAWA cell growth in a cell viability assay, IC50 = 0.02454 μM. |
SANGER |
HCC1954 |
Growth inhibition assay |
|
|
|
Inhibition of human HCC1954 cell growth in a cell viability assay, IC50 = 0.02487 μM. |
SANGER |
OVCAR-8 |
Growth inhibition assay |
|
|
|
Inhibition of human OVCAR-8 cell growth in a cell viability assay, IC50 = 0.02498 μM. |
SANGER |
G-401 |
Growth inhibition assay |
|
|
|
Inhibition of human G-401 cell growth in a cell viability assay, IC50 = 0.02511 μM. |
SANGER |
EFO-27 |
Growth inhibition assay |
|
|
|
Inhibition of human EFO-27 cell growth in a cell viability assay, IC50 = 0.02539 μM. |
SANGER |
MKN45 |
Growth inhibition assay |
|
|
|
Inhibition of human MKN45 cell growth in a cell viability assay, IC50 = 0.0254 μM. |
SANGER |
NCI-H1770 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1770 cell growth in a cell viability assay, IC50 = 0.02574 μM. |
SANGER |
PF-382 |
Growth inhibition assay |
|
|
|
Inhibition of human PF-382 cell growth in a cell viability assay, IC50 = 0.02587 μM. |
SANGER |
PANC-10-05 |
Growth inhibition assay |
|
|
|
Inhibition of human PANC-10-05 cell growth in a cell viability assay, IC50 = 0.02607 μM. |
SANGER |
OAW-42 |
Growth inhibition assay |
|
|
|
Inhibition of human OAW-42 cell growth in a cell viability assay, IC50 = 0.02697 μM. |
SANGER |
KP-N-YN |
Growth inhibition assay |
|
|
|
Inhibition of human KP-N-YN cell growth in a cell viability assay, IC50 = 0.02699 μM. |
SANGER |
NB1 |
Growth inhibition assay |
|
|
|
Inhibition of human NB1 cell growth in a cell viability assay, IC50 = 0.02712 μM. |
SANGER |
MMAC-SF |
Growth inhibition assay |
|
|
|
Inhibition of human MMAC-SF cell growth in a cell viability assay, IC50 = 0.02826 μM. |
SANGER |
ACHN |
Growth inhibition assay |
|
|
|
Inhibition of human ACHN cell growth in a cell viability assay, IC50 = 0.02857 μM. |
SANGER |
DV-90 |
Growth inhibition assay |
|
|
|
Inhibition of human DV-90 cell growth in a cell viability assay, IC50 = 0.02877 μM. |
SANGER |
LS-1034 |
Growth inhibition assay |
|
|
|
Inhibition of human LS-1034 cell growth in a cell viability assay, IC50 = 0.02898 μM. |
SANGER |
LB373-MEL-D |
Growth inhibition assay |
|
|
|
Inhibition of human LB373-MEL-D cell growth in a cell viability assay, IC50 = 0.02907 μM. |
SANGER |
C2BBe1 |
Growth inhibition assay |
|
|
|
Inhibition of human C2BBe1 cell growth in a cell viability assay, IC50 = 0.02933 μM. |
SANGER |
MS-1 |
Growth inhibition assay |
|
|
|
Inhibition of human MS-1 cell growth in a cell viability assay, IC50 = 0.02951 μM. |
SANGER |
CHP-126 |
Growth inhibition assay |
|
|
|
Inhibition of human CHP-126 cell growth in a cell viability assay, IC50 = 0.02981 μM. |
SANGER |
COLO-829 |
Growth inhibition assay |
|
|
|
Inhibition of human COLO-829 cell growth in a cell viability assay, IC50 = 0.02982 μM. |
SANGER |
LOUCY |
Growth inhibition assay |
|
|
|
Inhibition of human LOUCY cell growth in a cell viability assay, IC50 = 0.02992 μM. |
SANGER |
C3A |
Growth inhibition assay |
|
|
|
Inhibition of human C3A cell growth in a cell viability assay, IC50 = 0.03035 μM. |
SANGER |
CAL-33 |
Growth inhibition assay |
|
|
|
Inhibition of human CAL-33 cell growth in a cell viability assay, IC50 = 0.03066 μM. |
SANGER |
CCRF-CEM |
Growth inhibition assay |
|
|
|
Inhibition of human CCRF-CEM cell growth in a cell viability assay, IC50 = 0.03092 μM. |
SANGER |
SW1573 |
Growth inhibition assay |
|
|
|
Inhibition of human SW1573 cell growth in a cell viability assay, IC50 = 0.03105 μM. |
SANGER |
NCI-H82 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H82 cell growth in a cell viability assay, IC50 = 0.03109 μM. |
SANGER |
NCI-H748 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H748 cell growth in a cell viability assay, IC50 = 0.03129 μM. |
SANGER |
LB996-RCC |
Growth inhibition assay |
|
|
|
Inhibition of human LB996-RCC cell growth in a cell viability assay, IC50 = 0.03132 μM. |
SANGER |
23132-87 |
Growth inhibition assay |
|
|
|
Inhibition of human 23132-87 cell growth in a cell viability assay, IC50 = 0.0314 μM. |
SANGER |
U-118-MG |
Growth inhibition assay |
|
|
|
Inhibition of human U-118-MG cell growth in a cell viability assay, IC50 = 0.03189 μM. |
SANGER |
ATN-1 |
Growth inhibition assay |
|
|
|
Inhibition of human ATN-1 cell growth in a cell viability assay, IC50 = 0.03204 μM. |
SANGER |
LNCaP-Clone-FGC |
Growth inhibition assay |
|
|
|
Inhibition of human LNCaP-Clone-FGC cell growth in a cell viability assay, IC50 = 0.03219 μM. |
SANGER |
Ca-Ski |
Growth inhibition assay |
|
|
|
Inhibition of human Ca-Ski cell growth in a cell viability assay, IC50 = 0.03222 μM. |
SANGER |
769-P |
Growth inhibition assay |
|
|
|
Inhibition of human 769-P cell growth in a cell viability assay, IC50 = 0.03233 μM. |
SANGER |
SNB75 |
Growth inhibition assay |
|
|
|
Inhibition of human SNB75 cell growth in a cell viability assay, IC50 = 0.03259 μM. |
SANGER |
CMK |
Growth inhibition assay |
|
|
|
Inhibition of human CMK cell growth in a cell viability assay, IC50 = 0.03333 μM. |
SANGER |
LU-139 |
Growth inhibition assay |
|
|
|
Inhibition of human LU-139 cell growth in a cell viability assay, IC50 = 0.03363 μM. |
SANGER |
JVM-3 |
Growth inhibition assay |
|
|
|
Inhibition of human JVM-3 cell growth in a cell viability assay, IC50 = 0.03365 μM. |
SANGER |
NCI-H526 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H526 cell growth in a cell viability assay, IC50 = 0.03399 μM. |
SANGER |
NCI-H838 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H838 cell growth in a cell viability assay, IC50 = 0.03528 μM. |
SANGER |
CESS |
Growth inhibition assay |
|
|
|
Inhibition of human CESS cell growth in a cell viability assay, IC50 = 0.03536 μM. |
SANGER |
NCI-H446 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H446 cell growth in a cell viability assay, IC50 = 0.03544 μM. |
SANGER |
KARPAS-299 |
Growth inhibition assay |
|
|
|
Inhibition of human KARPAS-299 cell growth in a cell viability assay, IC50 = 0.03564 μM. |
SANGER |
NCI-H510A |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H510A cell growth in a cell viability assay, IC50 = 0.03608 μM. |
SANGER |
COR-L279 |
Growth inhibition assay |
|
|
|
Inhibition of human COR-L279 cell growth in a cell viability assay, IC50 = 0.0363 μM. |
SANGER |
HCE-T |
Growth inhibition assay |
|
|
|
Inhibition of human HCE-T cell growth in a cell viability assay, IC50 = 0.03631 μM. |
SANGER |
OE19 |
Growth inhibition assay |
|
|
|
Inhibition of human OE19 cell growth in a cell viability assay, IC50 = 0.03652 μM. |
SANGER |
MFE-280 |
Growth inhibition assay |
|
|
|
Inhibition of human MFE-280 cell growth in a cell viability assay, IC50 = 0.03656 μM. |
SANGER |
NCI-H345 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H345 cell growth in a cell viability assay, IC50 = 0.03699 μM. |
SANGER |
D-263MG |
Growth inhibition assay |
|
|
|
Inhibition of human D-263MG cell growth in a cell viability assay, IC50 = 0.03719 μM. |
SANGER |
Caov-3 |
Growth inhibition assay |
|
|
|
Inhibition of human Caov-3 cell growth in a cell viability assay, IC50 = 0.0372 μM. |
SANGER |
MC-IXC |
Growth inhibition assay |
|
|
|
Inhibition of human MC-IXC cell growth in a cell viability assay, IC50 = 0.03761 μM. |
SANGER |
SF126 |
Growth inhibition assay |
|
|
|
Inhibition of human SF126 cell growth in a cell viability assay, IC50 = 0.03831 μM. |
SANGER |
Raji |
Growth inhibition assay |
|
|
|
Inhibition of human Raji cell growth in a cell viability assay, IC50 = 0.0384 μM. |
SANGER |
SIMA |
Growth inhibition assay |
|
|
|
Inhibition of human SIMA cell growth in a cell viability assay, IC50 = 0.03844 μM. |
SANGER |
NCI-H596 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H596 cell growth in a cell viability assay, IC50 = 0.03887 μM. |
SANGER |
MOLT-4 |
Growth inhibition assay |
|
|
|
Inhibition of human MOLT-4 cell growth in a cell viability assay, IC50 = 0.0395 μM. |
SANGER |
HEC-1 |
Growth inhibition assay |
|
|
|
Inhibition of human HEC-1 cell growth in a cell viability assay, IC50 = 0.04044 μM. |
SANGER |
S-117 |
Growth inhibition assay |
|
|
|
Inhibition of human S-117 cell growth in a cell viability assay, IC50 = 0.04092 μM. |
SANGER |
NCI-H1651 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1651 cell growth in a cell viability assay, IC50 = 0.04128 μM. |
SANGER |
SCC-3 |
Growth inhibition assay |
|
|
|
Inhibition of human SCC-3 cell growth in a cell viability assay, IC50 = 0.04164 μM. |
SANGER |
GP5d |
Growth inhibition assay |
|
|
|
Inhibition of human GP5d cell growth in a cell viability assay, IC50 = 0.04172 μM. |
SANGER |
LC4-1 |
Growth inhibition assay |
|
|
|
Inhibition of human LC4-1 cell growth in a cell viability assay, IC50 = 0.0423 μM. |
SANGER |
RPMI-6666 |
Growth inhibition assay |
|
|
|
Inhibition of human RPMI-6666 cell growth in a cell viability assay, IC50 = 0.04265 μM. |
SANGER |
SK-N-DZ |
Growth inhibition assay |
|
|
|
Inhibition of human SK-N-DZ cell growth in a cell viability assay, IC50 = 0.04319 μM. |
SANGER |
HuO-3N1 |
Growth inhibition assay |
|
|
|
Inhibition of human HuO-3N1 cell growth in a cell viability assay, IC50 = 0.04325 μM. |
SANGER |
RH-1 |
Growth inhibition assay |
|
|
|
Inhibition of human RH-1 cell growth in a cell viability assay, IC50 = 0.04342 μM. |
SANGER |
CAL-120 |
Growth inhibition assay |
|
|
|
Inhibition of human CAL-120 cell growth in a cell viability assay, IC50 = 0.04409 μM. |
SANGER |
U-2-OS |
Growth inhibition assay |
|
|
|
Inhibition of human U-2-OS cell growth in a cell viability assay, IC50 = 0.04466 μM. |
SANGER |
MHH-NB-11 |
Growth inhibition assay |
|
|
|
Inhibition of human MHH-NB-11 cell growth in a cell viability assay, IC50 = 0.04506 μM. |
SANGER |
SK-MM-2 |
Growth inhibition assay |
|
|
|
Inhibition of human SK-MM-2 cell growth in a cell viability assay, IC50 = 0.04562 μM. |
SANGER |
HEL |
Growth inhibition assay |
|
|
|
Inhibition of human HEL cell growth in a cell viability assay, IC50 = 0.04625 μM. |
SANGER |
OE33 |
Growth inhibition assay |
|
|
|
Inhibition of human OE33 cell growth in a cell viability assay, IC50 = 0.0469 μM. |
SANGER |
DK-MG |
Growth inhibition assay |
|
|
|
Inhibition of human DK-MG cell growth in a cell viability assay, IC50 = 0.04719 μM. |
SANGER |
MKN1 |
Growth inhibition assay |
|
|
|
Inhibition of human MKN1 cell growth in a cell viability assay, IC50 = 0.04743 μM. |
SANGER |
COLO-320-HSR |
Growth inhibition assay |
|
|
|
Inhibition of human COLO-320-HSR cell growth in a cell viability assay, IC50 = 0.04796 μM. |
SANGER |
SBC-1 |
Growth inhibition assay |
|
|
|
Inhibition of human SBC-1 cell growth in a cell viability assay, IC50 = 0.04797 μM. |
SANGER |
SK-N-AS |
Growth inhibition assay |
|
|
|
Inhibition of human SK-N-AS cell growth in a cell viability assay, IC50 = 0.04851 μM. |
SANGER |
TE-441-T |
Growth inhibition assay |
|
|
|
Inhibition of human TE-441-T cell growth in a cell viability assay, IC50 = 0.04881 μM. |
SANGER |
OAW-28 |
Growth inhibition assay |
|
|
|
Inhibition of human OAW-28 cell growth in a cell viability assay, IC50 = 0.0503 μM. |
SANGER |
GOTO |
Growth inhibition assay |
|
|
|
Inhibition of human GOTO cell growth in a cell viability assay, IC50 = 0.05052 μM. |
SANGER |
COLO-800 |
Growth inhibition assay |
|
|
|
Inhibition of human COLO-800 cell growth in a cell viability assay, IC50 = 0.05125 μM. |
SANGER |
TCCSUP |
Growth inhibition assay |
|
|
|
Inhibition of human TCCSUP cell growth in a cell viability assay, IC50 = 0.05164 μM. |
SANGER |
NCI-H187 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H187 cell growth in a cell viability assay, IC50 = 0.05315 μM. |
SANGER |
GCIY |
Growth inhibition assay |
|
|
|
Inhibition of human GCIY cell growth in a cell viability assay, IC50 = 0.05346 μM. |
SANGER |
ML-2 |
Growth inhibition assay |
|
|
|
Inhibition of human ML-2 cell growth in a cell viability assay, IC50 = 0.0539 μM. |
SANGER |
SUP-T1 |
Growth inhibition assay |
|
|
|
Inhibition of human SUP-T1 cell growth in a cell viability assay, IC50 = 0.05468 μM. |
SANGER |
DJM-1 |
Growth inhibition assay |
|
|
|
Inhibition of human DJM-1 cell growth in a cell viability assay, IC50 = 0.05474 μM. |
SANGER |
EW-11 |
Growth inhibition assay |
|
|
|
Inhibition of human EW-11 cell growth in a cell viability assay, IC50 = 0.05478 μM. |
SANGER |
EM-2 |
Growth inhibition assay |
|
|
|
Inhibition of human EM-2 cell growth in a cell viability assay, IC50 = 0.05538 μM. |
SANGER |
NCI-H69 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H69 cell growth in a cell viability assay, IC50 = 0.05667 μM. |
SANGER |
MLMA |
Growth inhibition assay |
|
|
|
Inhibition of human MLMA cell growth in a cell viability assay, IC50 = 0.05751 μM. |
SANGER |
U031 |
Growth inhibition assay |
|
|
|
Inhibition of human U031 cell growth in a cell viability assay, IC50 = 0.05767 μM. |
SANGER |
UACC-893 |
Growth inhibition assay |
|
|
|
Inhibition of human UACC-893 cell growth in a cell viability assay, IC50 = 0.05875 μM. |
SANGER |
no-11 |
Growth inhibition assay |
|
|
|
Inhibition of human no-11 cell growth in a cell viability assay, IC50 = 0.05886 μM. |
SANGER |
HCC2218 |
Growth inhibition assay |
|
|
|
Inhibition of human HCC2218 cell growth in a cell viability assay, IC50 = 0.05894 μM. |
SANGER |
NCI-H1304 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1304 cell growth in a cell viability assay, IC50 = 0.05907 μM. |
SANGER |
SHP-77 |
Growth inhibition assay |
|
|
|
Inhibition of human SHP-77 cell growth in a cell viability assay, IC50 = 0.05913 μM. |
SANGER |
COLO-792 |
Growth inhibition assay |
|
|
|
Inhibition of human COLO-792 cell growth in a cell viability assay, IC50 = 0.05956 μM. |
SANGER |
HPAF-II |
Growth inhibition assay |
|
|
|
Inhibition of human HPAF-II cell growth in a cell viability assay, IC50 = 0.06193 μM. |
SANGER |
NB10 |
Growth inhibition assay |
|
|
|
Inhibition of human NB10 cell growth in a cell viability assay, IC50 = 0.06319 μM. |
SANGER |
LB771-HNC |
Growth inhibition assay |
|
|
|
Inhibition of human LB771-HNC cell growth in a cell viability assay, IC50 = 0.06412 μM. |
SANGER |
COLO-824 |
Growth inhibition assay |
|
|
|
Inhibition of human COLO-824 cell growth in a cell viability assay, IC50 = 0.06463 μM. |
SANGER |
LB2241-RCC |
Growth inhibition assay |
|
|
|
Inhibition of human LB2241-RCC cell growth in a cell viability assay, IC50 = 0.06604 μM. |
SANGER |
NCI-H1963 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1963 cell growth in a cell viability assay, IC50 = 0.06618 μM. |
SANGER |
UACC-62 |
Growth inhibition assay |
|
|
|
Inhibition of human UACC-62 cell growth in a cell viability assay, IC50 = 0.06644 μM. |
SANGER |
NB5 |
Growth inhibition assay |
|
|
|
Inhibition of human NB5 cell growth in a cell viability assay, IC50 = 0.06659 μM. |
SANGER |
CCF-STTG1 |
Growth inhibition assay |
|
|
|
Inhibition of human CCF-STTG1 cell growth in a cell viability assay, IC50 = 0.06729 μM. |
SANGER |
KG-1 |
Growth inhibition assay |
|
|
|
Inhibition of human KG-1 cell growth in a cell viability assay, IC50 = 0.06743 μM. |
SANGER |
MN-60 |
Growth inhibition assay |
|
|
|
Inhibition of human MN-60 cell growth in a cell viability assay, IC50 = 0.06923 μM. |
SANGER |
NCI-H524 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H524 cell growth in a cell viability assay, IC50 = 0.07001 μM. |
SANGER |
KLE |
Growth inhibition assay |
|
|
|
Inhibition of human KLE cell growth in a cell viability assay, IC50 = 0.07024 μM. |
SANGER |
CAL-62 |
Growth inhibition assay |
|
|
|
Inhibition of human CAL-62 cell growth in a cell viability assay, IC50 = 0.07159 μM. |
SANGER |
P31-FUJ |
Growth inhibition assay |
|
|
|
Inhibition of human P31-FUJ cell growth in a cell viability assay, IC50 = 0.07207 μM. |
SANGER |
NCI-H1694 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1694 cell growth in a cell viability assay, IC50 = 0.07284 μM. |
SANGER |
ARH-77 |
Growth inhibition assay |
|
|
|
Inhibition of human ARH-77 cell growth in a cell viability assay, IC50 = 0.07505 μM. |
SANGER |
L-540 |
Growth inhibition assay |
|
|
|
Inhibition of human L-540 cell growth in a cell viability assay, IC50 = 0.0752 μM. |
SANGER |
U-698-M |
Growth inhibition assay |
|
|
|
Inhibition of human U-698-M cell growth in a cell viability assay, IC50 = 0.07736 μM. |
SANGER |
NCI-H2126 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H2126 cell growth in a cell viability assay, IC50 = 0.0793 μM. |
SANGER |
KU-19-19 |
Growth inhibition assay |
|
|
|
Inhibition of human KU-19-19 cell growth in a cell viability assay, IC50 = 0.08 μM. |
SANGER |
KMOE-2 |
Growth inhibition assay |
|
|
|
Inhibition of human KMOE-2 cell growth in a cell viability assay, IC50 = 0.08289 μM. |
SANGER |
OMC-1 |
Growth inhibition assay |
|
|
|
Inhibition of human OMC-1 cell growth in a cell viability assay, IC50 = 0.08296 μM. |
SANGER |
CAKI-1 |
Growth inhibition assay |
|
|
|
Inhibition of human CAKI-1 cell growth in a cell viability assay, IC50 = 0.08345 μM. |
SANGER |
NCI-H2141 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H2141 cell growth in a cell viability assay, IC50 = 0.08497 μM. |
SANGER |
BHT-101 |
Growth inhibition assay |
|
|
|
Inhibition of human BHT-101 cell growth in a cell viability assay, IC50 = 0.0881 μM. |
SANGER |
SK-N-FI |
Growth inhibition assay |
|
|
|
Inhibition of human SK-N-FI cell growth in a cell viability assay, IC50 = 0.08824 μM. |
SANGER |
YAPC |
Growth inhibition assay |
|
|
|
Inhibition of human YAPC cell growth in a cell viability assay, IC50 = 0.08956 μM. |
SANGER |
NCI-SNU-5 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-SNU-5 cell growth in a cell viability assay, IC50 = 0.09142 μM. |
SANGER |
PLC-PRF-5 |
Growth inhibition assay |
|
|
|
Inhibition of human PLC-PRF-5 cell growth in a cell viability assay, IC50 = 0.09183 μM. |
SANGER |
LU-134-A |
Growth inhibition assay |
|
|
|
Inhibition of human LU-134-A cell growth in a cell viability assay, IC50 = 0.09335 μM. |
SANGER |
EHEB |
Growth inhibition assay |
|
|
|
Inhibition of human EHEB cell growth in a cell viability assay, IC50 = 0.09408 μM. |
SANGER |
HH |
Growth inhibition assay |
|
|
|
Inhibition of human HH cell growth in a cell viability assay, IC50 = 0.09594 μM. |
SANGER |
NCI-H747 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H747 cell growth in a cell viability assay, IC50 = 0.10022 μM. |
SANGER |
SAS |
Growth inhibition assay |
|
|
|
Inhibition of human SAS cell growth in a cell viability assay, IC50 = 0.10642 μM. |
SANGER |
MZ7-mel |
Growth inhibition assay |
|
|
|
Inhibition of human MZ7-mel cell growth in a cell viability assay, IC50 = 0.10722 μM. |
SANGER |
HC-1 |
Growth inhibition assay |
|
|
|
Inhibition of human HC-1 cell growth in a cell viability assay, IC50 = 0.10942 μM. |
SANGER |
GB-1 |
Growth inhibition assay |
|
|
|
Inhibition of human GB-1 cell growth in a cell viability assay, IC50 = 0.11367 μM. |
SANGER |
UACC-257 |
Growth inhibition assay |
|
|
|
Inhibition of human UACC-257 cell growth in a cell viability assay, IC50 = 0.11539 μM. |
SANGER |
CAS-1 |
Growth inhibition assay |
|
|
|
Inhibition of human CAS-1 cell growth in a cell viability assay, IC50 = 0.11792 μM. |
SANGER |
EW-3 |
Growth inhibition assay |
|
|
|
Inhibition of human EW-3 cell growth in a cell viability assay, IC50 = 0.11799 μM. |
SANGER |
EVSA-T |
Growth inhibition assay |
|
|
|
Inhibition of human EVSA-T cell growth in a cell viability assay, IC50 = 0.12153 μM. |
SANGER |
RCM-1 |
Growth inhibition assay |
|
|
|
Inhibition of human RCM-1 cell growth in a cell viability assay, IC50 = 0.12154 μM. |
SANGER |
U-87-MG |
Growth inhibition assay |
|
|
|
Inhibition of human U-87-MG cell growth in a cell viability assay, IC50 = 0.13181 μM. |
SANGER |
Becker |
Growth inhibition assay |
|
|
|
Inhibition of human Becker cell growth in a cell viability assay, IC50 = 0.1349 μM. |
SANGER |
IST-MES1 |
Growth inhibition assay |
|
|
|
Inhibition of human IST-MES1 cell growth in a cell viability assay, IC50 = 0.1384 μM. |
SANGER |
J-RT3-T3-5 |
Growth inhibition assay |
|
|
|
Inhibition of human J-RT3-T3-5 cell growth in a cell viability assay, IC50 = 0.14069 μM. |
SANGER |
NCI-H1650 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1650 cell growth in a cell viability assay, IC50 = 0.14718 μM. |
SANGER |
EW-24 |
Growth inhibition assay |
|
|
|
Inhibition of human EW-24 cell growth in a cell viability assay, IC50 = 0.14946 μM. |
SANGER |
LS-513 |
Growth inhibition assay |
|
|
|
Inhibition of human LS-513 cell growth in a cell viability assay, IC50 = 0.15395 μM. |
SANGER |
HCT-15 |
Growth inhibition assay |
|
|
|
Inhibition of human HCT-15 cell growth in a cell viability assay, IC50 = 0.15475 μM. |
SANGER |
FADU |
Growth inhibition assay |
|
|
|
Inhibition of human FADU cell growth in a cell viability assay, IC50 = 0.16878 μM. |
SANGER |
NCI-H1395 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1395 cell growth in a cell viability assay, IC50 = 0.17593 μM. |
SANGER |
C8166 |
Growth inhibition assay |
|
|
|
Inhibition of human C8166 cell growth in a cell viability assay, IC50 = 0.18849 μM. |
SANGER |
NCI-SNU-16 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-SNU-16 cell growth in a cell viability assay, IC50 = 0.18901 μM. |
SANGER |
HCC1599 |
Growth inhibition assay |
|
|
|
Inhibition of human HCC1599 cell growth in a cell viability assay, IC50 = 0.19405 μM. |
SANGER |
NCI-H1563 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1563 cell growth in a cell viability assay, IC50 = 0.19867 μM. |
SANGER |
GAK |
Growth inhibition assay |
|
|
|
Inhibition of human GAK cell growth in a cell viability assay, IC50 = 0.19921 μM. |
SANGER |
BT-474 |
Growth inhibition assay |
|
|
|
Inhibition of human BT-474 cell growth in a cell viability assay, IC50 = 0.20988 μM. |
SANGER |
HDLM-2 |
Growth inhibition assay |
|
|
|
Inhibition of human HDLM-2 cell growth in a cell viability assay, IC50 = 0.21488 μM. |
SANGER |
TT |
Growth inhibition assay |
|
|
|
Inhibition of human TT cell growth in a cell viability assay, IC50 = 0.21689 μM. |
SANGER |
GDM-1 |
Growth inhibition assay |
|
|
|
Inhibition of human GDM-1 cell growth in a cell viability assay, IC50 = 0.23023 μM. |
SANGER |
A704 |
Growth inhibition assay |
|
|
|
Inhibition of human A704 cell growth in a cell viability assay, IC50 = 0.24744 μM. |
SANGER |
EKVX |
Growth inhibition assay |
|
|
|
Inhibition of human EKVX cell growth in a cell viability assay, IC50 = 0.25047 μM. |
SANGER |
COR-L88 |
Growth inhibition assay |
|
|
|
Inhibition of human COR-L88 cell growth in a cell viability assay, IC50 = 0.26639 μM. |
SANGER |
NCI-H1155 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1155 cell growth in a cell viability assay, IC50 = 0.28473 μM. |
SANGER |
MSTO-211H |
Growth inhibition assay |
|
|
|
Inhibition of human MSTO-211H cell growth in a cell viability assay, IC50 = 0.293 μM. |
SANGER |
NCI-H650 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H650 cell growth in a cell viability assay, IC50 = 0.29624 μM. |
SANGER |
KMS-12-PE |
Growth inhibition assay |
|
|
|
Inhibition of human KMS-12-PE cell growth in a cell viability assay, IC50 = 0.29669 μM. |
SANGER |
HAL-01 |
Growth inhibition assay |
|
|
|
Inhibition of human HAL-01 cell growth in a cell viability assay, IC50 = 0.30096 μM. |
SANGER |
K-562 |
Growth inhibition assay |
|
|
|
Inhibition of human K-562 cell growth in a cell viability assay, IC50 = 0.3054 μM. |
SANGER |
C32 |
Growth inhibition assay |
|
|
|
Inhibition of human C32 cell growth in a cell viability assay, IC50 = 0.30946 μM. |
SANGER |
NCI-H1755 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1755 cell growth in a cell viability assay, IC50 = 0.30994 μM. |
SANGER |
SW1088 |
Growth inhibition assay |
|
|
|
Inhibition of human SW1088 cell growth in a cell viability assay, IC50 = 0.32404 μM. |
SANGER |
MDA-MB-175-VII |
Growth inhibition assay |
|
|
|
Inhibition of human MDA-MB-175-VII cell growth in a cell viability assay, IC50 = 0.32976 μM. |
SANGER |
SW1417 |
Growth inhibition assay |
|
|
|
Inhibition of human SW1417 cell growth in a cell viability assay, IC50 = 0.33545 μM. |
SANGER |
D-502MG |
Growth inhibition assay |
|
|
|
Inhibition of human D-502MG cell growth in a cell viability assay, IC50 = 0.34318 μM. |
SANGER |
COLO-684 |
Growth inhibition assay |
|
|
|
Inhibition of human COLO-684 cell growth in a cell viability assay, IC50 = 0.34465 μM. |
SANGER |
EC-GI-10 |
Growth inhibition assay |
|
|
|
Inhibition of human EC-GI-10 cell growth in a cell viability assay, IC50 = 0.35518 μM. |
SANGER |
DMS-53 |
Growth inhibition assay |
|
|
|
Inhibition of human DMS-53 cell growth in a cell viability assay, IC50 = 0.37965 μM. |
SANGER |
KOSC-2 |
Growth inhibition assay |
|
|
|
Inhibition of human KOSC-2 cell growth in a cell viability assay, IC50 = 0.42501 μM. |
SANGER |
SCC-9 |
Growth inhibition assay |
|
|
|
Inhibition of human SCC-9 cell growth in a cell viability assay, IC50 = 0.44705 μM. |
SANGER |
MHH-CALL-2 |
Growth inhibition assay |
|
|
|
Inhibition of human MHH-CALL-2 cell growth in a cell viability assay, IC50 = 0.4684 μM. |
SANGER |
K052 |
Growth inhibition assay |
|
|
|
Inhibition of human K052 cell growth in a cell viability assay, IC50 = 0.49549 μM. |
SANGER |
HCC1187 |
Growth inhibition assay |
|
|
|
Inhibition of human HCC1187 cell growth in a cell viability assay, IC50 = 0.5052 μM. |
SANGER |
Calu-3 |
Growth inhibition assay |
|
|
|
Inhibition of human Calu-3 cell growth in a cell viability assay, IC50 = 0.51611 μM. |
SANGER |
BT-20 |
Growth inhibition assay |
|
|
|
Inhibition of human BT-20 cell growth in a cell viability assay, IC50 = 0.52627 μM. |
SANGER |
QIMR-WIL |
Growth inhibition assay |
|
|
|
Inhibition of human QIMR-WIL cell growth in a cell viability assay, IC50 = 0.52733 μM. |
SANGER |
HT-1197 |
Growth inhibition assay |
|
|
|
Inhibition of human HT-1197 cell growth in a cell viability assay, IC50 = 0.53823 μM. |
SANGER |
SK-MEL-1 |
Growth inhibition assay |
|
|
|
Inhibition of human SK-MEL-1 cell growth in a cell viability assay, IC50 = 0.5512 μM. |
SANGER |
RPMI-8866 |
Growth inhibition assay |
|
|
|
Inhibition of human RPMI-8866 cell growth in a cell viability assay, IC50 = 0.55679 μM. |
SANGER |
RXF393 |
Growth inhibition assay |
|
|
|
Inhibition of human RXF393 cell growth in a cell viability assay, IC50 = 0.5569 μM. |
SANGER |
Hs-578-T |
Growth inhibition assay |
|
|
|
Inhibition of human Hs-578-T cell growth in a cell viability assay, IC50 = 0.57063 μM. |
SANGER |
NCI-H889 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H889 cell growth in a cell viability assay, IC50 = 0.57112 μM. |
SANGER |
NCI-H1623 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1623 cell growth in a cell viability assay, IC50 = 0.62462 μM. |
SANGER |
NCI-H23 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H23 cell growth in a cell viability assay, IC50 = 0.64169 μM. |
SANGER |
K5 |
Growth inhibition assay |
|
|
|
Inhibition of human K5 cell growth in a cell viability assay, IC50 = 0.64572 μM. |
SANGER |
LAN-6 |
Growth inhibition assay |
|
|
|
Inhibition of human LAN-6 cell growth in a cell viability assay, IC50 = 0.67049 μM. |
SANGER |
BOKU |
Growth inhibition assay |
|
|
|
Inhibition of human BOKU cell growth in a cell viability assay, IC50 = 0.67371 μM. |
SANGER |
SW1463 |
Growth inhibition assay |
|
|
|
Inhibition of human SW1463 cell growth in a cell viability assay, IC50 = 0.68431 μM. |
SANGER |
SNU-C1 |
Growth inhibition assay |
|
|
|
Inhibition of human SNU-C1 cell growth in a cell viability assay, IC50 = 0.68686 μM. |
SANGER |
HO-1-N-1 |
Growth inhibition assay |
|
|
|
Inhibition of human HO-1-N-1 cell growth in a cell viability assay, IC50 = 0.71087 μM. |
SANGER |
SW780 |
Growth inhibition assay |
|
|
|
Inhibition of human SW780 cell growth in a cell viability assay, IC50 = 0.73452 μM. |
SANGER |
HT55 |
Growth inhibition assay |
|
|
|
Inhibition of human HT55 cell growth in a cell viability assay, IC50 = 0.74422 μM. |
SANGER |
NCI-H1417 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1417 cell growth in a cell viability assay, IC50 = 0.77226 μM. |
SANGER |
no-10 |
Growth inhibition assay |
|
|
|
Inhibition of human no-10 cell growth in a cell viability assay, IC50 = 0.77735 μM. |
SANGER |
NCI-H1693 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1693 cell growth in a cell viability assay, IC50 = 0.78573 μM. |
SANGER |
MKN7 |
Growth inhibition assay |
|
|
|
Inhibition of human MKN7 cell growth in a cell viability assay, IC50 = 0.80612 μM. |
SANGER |
NCI-H2227 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H2227 cell growth in a cell viability assay, IC50 = 0.82632 μM. |
SANGER |
MDA-MB-415 |
Growth inhibition assay |
|
|
|
Inhibition of human MDA-MB-415 cell growth in a cell viability assay, IC50 = 0.83664 μM. |
SANGER |
RO82-W-1 |
Growth inhibition assay |
|
|
|
Inhibition of human RO82-W-1 cell growth in a cell viability assay, IC50 = 0.85758 μM. |
SANGER |
LN-405 |
Growth inhibition assay |
|
|
|
Inhibition of human LN-405 cell growth in a cell viability assay, IC50 = 0.85906 μM. |
SANGER |
HSC-4 |
Growth inhibition assay |
|
|
|
Inhibition of human HSC-4 cell growth in a cell viability assay, IC50 = 0.8627 μM. |
SANGER |
TE-5 |
Growth inhibition assay |
|
|
|
Inhibition of human TE-5 cell growth in a cell viability assay, IC50 = 0.89654 μM. |
SANGER |
COLO-678 |
Growth inhibition assay |
|
|
|
Inhibition of human COLO-678 cell growth in a cell viability assay, IC50 = 0.91787 μM. |
SANGER |
NCI-H28 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H28 cell growth in a cell viability assay, IC50 = 0.92674 μM. |
SANGER |
SKG-IIIa |
Growth inhibition assay |
|
|
|
Inhibition of human SKG-IIIa cell growth in a cell viability assay, IC50 = 0.96828 μM. |
SANGER |
EFE-184 |
Growth inhibition assay |
|
|
|
Inhibition of human EFE-184 cell growth in a cell viability assay, IC50 = 0.98641 μM. |
SANGER |
NCI-H2081 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H2081 cell growth in a cell viability assay, IC50 = 1.02225 μM. |
SANGER |
AsPC-1 |
Growth inhibition assay |
|
|
|
Inhibition of human AsPC-1 cell growth in a cell viability assay, IC50 = 1.1379 μM. |
SANGER |
HL-60 |
Growth inhibition assay |
|
|
|
Inhibition of human HL-60 cell growth in a cell viability assay, IC50 = 1.15142 μM. |
SANGER |
DG-75 |
Growth inhibition assay |
|
|
|
Inhibition of human DG-75 cell growth in a cell viability assay, IC50 = 1.17579 μM. |
SANGER |
ECC4 |
Growth inhibition assay |
|
|
|
Inhibition of human ECC4 cell growth in a cell viability assay, IC50 = 1.40988 μM. |
SANGER |
NCI-H1793 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1793 cell growth in a cell viability assay, IC50 = 1.44791 μM. |
SANGER |
DMS-114 |
Growth inhibition assay |
|
|
|
Inhibition of human DMS-114 cell growth in a cell viability assay, IC50 = 1.49895 μM. |
SANGER |
LU-165 |
Growth inhibition assay |
|
|
|
Inhibition of human LU-165 cell growth in a cell viability assay, IC50 = 1.65167 μM. |
SANGER |
RL |
Growth inhibition assay |
|
|
|
Inhibition of human RL cell growth in a cell viability assay, IC50 = 1.82434 μM. |
SANGER |
RCC10RGB |
Growth inhibition assay |
|
|
|
Inhibition of human RCC10RGB cell growth in a cell viability assay, IC50 = 1.85255 μM. |
SANGER |
SW684 |
Growth inhibition assay |
|
|
|
Inhibition of human SW684 cell growth in a cell viability assay, IC50 = 1.86651 μM. |
SANGER |
SK-MEL-28 |
Growth inhibition assay |
|
|
|
Inhibition of human SK-MEL-28 cell growth in a cell viability assay, IC50 = 1.91124 μM. |
SANGER |
NCI-H1092 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1092 cell growth in a cell viability assay, IC50 = 1.96115 μM. |
SANGER |
ME-180 |
Growth inhibition assay |
|
|
|
Inhibition of human ME-180 cell growth in a cell viability assay, IC50 = 2.18336 μM. |
SANGER |
T47D |
Growth inhibition assay |
|
|
|
Inhibition of human T47D cell growth in a cell viability assay, IC50 = 2.27999 μM. |
SANGER |
NCI-H1882 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1882 cell growth in a cell viability assay, IC50 = 2.35612 μM. |
SANGER |
SR |
Growth inhibition assay |
|
|
|
Inhibition of human SR cell growth in a cell viability assay, IC50 = 2.62076 μM. |
SANGER |
KNS-81-FD |
Growth inhibition assay |
|
|
|
Inhibition of human KNS-81-FD cell growth in a cell viability assay, IC50 = 2.79489 μM. |
SANGER |
SW948 |
Growth inhibition assay |
|
|
|
Inhibition of human SW948 cell growth in a cell viability assay, IC50 = 3.06819 μM. |
SANGER |
D-392MG |
Growth inhibition assay |
|
|
|
Inhibition of human D-392MG cell growth in a cell viability assay, IC50 = 3.13491 μM. |
SANGER |
NCI-N87 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-N87 cell growth in a cell viability assay, IC50 = 3.16494 μM. |
SANGER |
MDA-MB-453 |
Growth inhibition assay |
|
|
|
Inhibition of human MDA-MB-453 cell growth in a cell viability assay, IC50 = 3.27952 μM. |
SANGER |
MDA-MB-157 |
Growth inhibition assay |
|
|
|
Inhibition of human MDA-MB-157 cell growth in a cell viability assay, IC50 = 3.32918 μM. |
SANGER |
NCI-H1993 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1993 cell growth in a cell viability assay, IC50 = 3.45309 μM. |
SANGER |
NCI-H716 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H716 cell growth in a cell viability assay, IC50 = 3.6086 μM. |
SANGER |
DOK |
Growth inhibition assay |
|
|
|
Inhibition of human DOK cell growth in a cell viability assay, IC50 = 3.7595 μM. |
SANGER |
CAL-148 |
Growth inhibition assay |
|
|
|
Inhibition of human CAL-148 cell growth in a cell viability assay, IC50 = 3.87974 μM. |
SANGER |
Mewo |
Growth inhibition assay |
|
|
|
Inhibition of human Mewo cell growth in a cell viability assay, IC50 = 4.57285 μM. |
SANGER |
A498 |
Growth inhibition assay |
|
|
|
Inhibition of human A498 cell growth in a cell viability assay, IC50 = 4.60511 μM. |
SANGER |
HN |
Growth inhibition assay |
|
|
|
Inhibition of human HN cell growth in a cell viability assay, IC50 = 4.98854 μM. |
SANGER |
NCI-H2196 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H2196 cell growth in a cell viability assay, IC50 = 5.1728 μM. |
SANGER |
MFM-223 |
Growth inhibition assay |
|
|
|
Inhibition of human MFM-223 cell growth in a cell viability assay, IC50 = 5.33188 μM. |
SANGER |
NOMO-1 |
Growth inhibition assay |
|
|
|
Inhibition of human NOMO-1 cell growth in a cell viability assay, IC50 = 5.44235 μM. |
SANGER |
HCC1419 |
Growth inhibition assay |
|
|
|
Inhibition of human HCC1419 cell growth in a cell viability assay, IC50 = 5.73518 μM. |
SANGER |
NCI-H322M |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H322M cell growth in a cell viability assay, IC50 = 7.1211 μM. |
SANGER |
FTC-133 |
Growth inhibition assay |
|
|
|
Inhibition of human FTC-133 cell growth in a cell viability assay, IC50 = 7.35538 μM. |
SANGER |
CAL-54 |
Growth inhibition assay |
|
|
|
Inhibition of human CAL-54 cell growth in a cell viability assay, IC50 = 7.70904 μM. |
SANGER |
SU-DHL-1 |
Growth inhibition assay |
|
|
|
Inhibition of human SU-DHL-1 cell growth in a cell viability assay, IC50 = 7.98032 μM. |
SANGER |
EFM-19 |
Growth inhibition assay |
|
|
|
Inhibition of human EFM-19 cell growth in a cell viability assay, IC50 = 9.59286 μM. |
SANGER |
SNU-475 |
Growth inhibition assay |
|
|
|
Inhibition of human SNU-475 cell growth in a cell viability assay, IC50 = 10.2974 μM. |
SANGER |
NCI-H1522 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1522 cell growth in a cell viability assay, IC50 = 10.3239 μM. |
SANGER |
BB49-HNC |
Growth inhibition assay |
|
|
|
Inhibition of human BB49-HNC cell growth in a cell viability assay, IC50 = 13.6024 μM. |
SANGER |
SK-MEL-24 |
Growth inhibition assay |
|
|
|
Inhibition of human SK-MEL-24 cell growth in a cell viability assay, IC50 = 15.0425 μM. |
SANGER |
JVM-2 |
Growth inhibition assay |
|
|
|
Inhibition of human JVM-2 cell growth in a cell viability assay, IC50 = 16.0832 μM. |
SANGER |
L-428 |
Growth inhibition assay |
|
|
|
Inhibition of human L-428 cell growth in a cell viability assay, IC50 = 16.7299 μM. |
SANGER |
ES5 |
Growth inhibition assay |
|
|
|
Inhibition of human ES5 cell growth in a cell viability assay, IC50 = 18.363 μM. |
SANGER |
NCI-H719 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H719 cell growth in a cell viability assay, IC50 = 23.5306 μM. |
SANGER |
NCI-H1436 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1436 cell growth in a cell viability assay, IC50 = 25.0093 μM. |
SANGER |
IM-9 |
Growth inhibition assay |
|
|
|
Inhibition of human IM-9 cell growth in a cell viability assay, IC50 = 28.675 μM. |
SANGER |
GMS-10 |
Growth inhibition assay |
|
|
|
Inhibition of human GMS-10 cell growth in a cell viability assay, IC50 = 30.4152 μM. |
SANGER |
MDA-MB-134-VI |
Growth inhibition assay |
|
|
|
Inhibition of human MDA-MB-134-VI cell growth in a cell viability assay, IC50 = 34.6397 μM. |
SANGER |
NCI-H2452 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H2452 cell growth in a cell viability assay, IC50 = 38.1671 μM. |
SANGER |
NCI-H720 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H720 cell growth in a cell viability assay, IC50 = 44.2062 μM. |
SANGER |
NCI-H1838 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1838 cell growth in a cell viability assay, IC50 = 46.4687 μM. |
SANGER |
SiHa |
Growth inhibition assay |
|
|
|
Inhibition of human SiHa cell growth in a cell viability assay, IC50 = 49.1123 μM. |
SANGER |
HL60 |
Cytotoxicity assay |
|
48 hrs |
|
Cytotoxicity against human HL60 cells assessed as cell viability after 48 hrs by celltiter-blue assay, IC50 = 0.007 μM. |
22582991 |
HeLa |
Function assay |
|
|
|
Inhibition of SERCA in human HeLa cells assessed as increase in cytosolic calcium level measured over 300 secs by Fluo-4 NW dye based FLIPR analysis, IC50 = 0.0285 μM. |
29636219 |
TSU-Pr1 |
Function assay |
|
|
|
Loss of clonogenic survival of human prostate cancer TSU-Pr1 cells, LC50 = 0.03 μM. |
11741487 |
K562 |
Cytotoxicity assay |
|
48 hrs |
|
Cytotoxicity against human K562 cells assessed as cell viability after 48 hrs by celltiter-blue assay, IC50 = 0.17 μM. |
22582991 |
MDCK |
Function assay |
1 uM |
|
|
Elevation of drug-induced intracellular calcium level in MDCK cells at 1 uM, Activity = 0.216 μM. |
18181576 |
CCRF-CEM |
Cytotoxicity assay |
|
48 hrs |
|
Cytotoxicity against human CCRF-CEM cells assessed as cell viability after 48 hrs by celltiter-blue assay, IC50 = 0.27 μM. |
22582991 |
EL4 |
Cytotoxicity assay |
|
48 hrs |
|
Cytotoxicity against mouse EL4 cells assessed as growth inhibition after 48 hrs by sulforhodamine B assay, IC50 = 1.4 μM. |
25951057 |
McCoy |
Cytotoxicity assay |
|
|
|
Cytotoxicity against mouse McCoy cells assessed as growth inhibition, IC50 = 2 μM. |
25951057 |
MCF10A |
Cytotoxicity assay |
|
|
|
Cytotoxicity against human MCF10A cells assessed as growth inhibition, IC50 = 2.4 μM. |
25951057 |
PC3 |
Cytotoxicity assay |
|
48 hrs |
|
Cytotoxicity against human PC3 cells assessed as growth inhibition after 48 hrs by sulforhodamine B assay, IC50 = 2.4 μM. |
25951057 |
MCF7 |
Cytotoxicity assay |
|
48 hrs |
|
Cytotoxicity against human MCF7 cells assessed as growth inhibition after 48 hrs by sulforhodamine B assay, IC50 = 2.7 μM. |
25951057 |
COS7 |
Autophagy assay |
2.5 uM |
48 hrs |
|
Induction of autophagy in african green monkey COS7 cells expressing EGFP-HDQ74 assessed as EGFP-HDQ74 aggregation at 2.5 uM after 48 hrs in presence of 50 uM ALLM |
18391949 |
PC12 |
Autophagy assay |
2.5 uM |
24 hrs |
|
Induction of autophagy in rat stable inducible PC12 cells expressing A53T alpha-synuclein assessed as A53T alpha-synuclein clearance at 2.5 uM after 24 hrs by densitometric analysis in presence of 50 uM ALLM |
18391949 |
COS7 |
Autophagy assay |
2.5 uM |
2 hrs |
|
Induction of autophagy in african green monkey COS7 cells assessed as increase in LC-3-2 positive vesicles at 2.5 uM after 2 hrs by immunofluorescence analysis |
18391949 |
COS7 |
Autophagy assay |
2.5 uM |
2 hrs |
|
Induction of autophagy in african green monkey COS7 cells assessed as increase in steady state LC-3 positive vesicles at 2.5 uM after 2 hrs by immunofluorescence analysis |
18391949 |
COS7 |
Autophagy assay |
10 uM |
48 hrs |
|
Induction of autophagy in african green monkey COS7 cells expressing EGFP-Atg5 assessed as increase in Atg5 level at 10 uM after 48 hrs by immunoblotting analysis |
18391949 |
COS7 |
Autophagy assay |
2.5 uM |
48 hrs |
|
Induction of autophagy in african green monkey COS7 cells expressing EGFP-Atg5 assessed as increase in Atg5 level at 2.5 uM after 48 hrs by immunoblotting analysis |
18391949 |
mouse neural precursor cells |
Function assay |
|
|
|
Inhibition of neurosphere proliferation of mouse neural precursor cells by MTT assay |
17417631 |
HeLa |
Function assay |
1 uM |
6 hrs |
|
Induction of endoplasmic reticulum stress in human HeLa cells assessed as upregulation of CHOP mRNA expression at 1 uM after 6 hrs by RT-PCR analysis |
26428873 |
HeLa |
Function assay |
1 uM |
6 hrs |
|
Induction of endoplasmic reticulum stress in human HeLa cells assessed as upregulation of Bip mRNA expression at 1 uM after 6 hrs by RT-PCR analysis |
26428873 |
HeLaS3 |
Function assay |
1 uM |
|
|
Induction of Ca2+ release from endoplasmic reticulum into cytosol in human HeLaS3 cells at 1 uM by fura-2/AM-based spectrofluorometric analysis |
26428873 |